Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Syndrome

• Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome
• A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
• Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
• Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Sivelestat) VI
• Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
• Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
• Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome
• Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause
• Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
• Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
• Protecting the Eyes of Gamers With Lubricating Eyedrops
• Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass
• Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).
• A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
• Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome
• Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity
• Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS
• Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
• Using Mirabegron to Increase BP in Patients With POTS
• Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome
• The Effects of Ultrasound Guided Ozone and Lidocaine Injections in Piriformis Syndrome
• A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
• Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelo
• Chiglitazar/Metformin in Non-obese Women With PCOS
• Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome
• A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome
• A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
• A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only)
• Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study
• Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
• Topical Cannabidiol for Treating Carpal Tunnel Syndrome
• Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
• A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
• CyFluATG in Lower Risk MDS
• Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population
• Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
• PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes
• Early Bolus Surfactant Replacement Therapy Versus Standard Care in Term Neonates With Meconium Aspiration Syndrome
• Clemastine Treatment in Individuals With Williams Syndrome
• Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome
• Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
• Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations
• Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial.
• COMMETS- Combination MCI Metabolic Syndrome
• Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
• Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
• Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
• Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
• Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
• Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
• Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
• Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
• Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction
• Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
• Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• The Effect of Colchicine on Inflammation in ACS Patients
• Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
• Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
• A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
• Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea
• Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
• Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism
• Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
• To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
• Xeomin vs Botox for Treatment of Overactive Bladder Syndrome
• Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment
• Study of V117957 in Overactive Bladder Syndrome
• LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
• Anti-CD38 Antibody Treating Evans Syndrome
• Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome
• Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
• Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
• Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
• Defibrotide Dose-escalation for SOS Post-HSCT
• Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
• A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
• PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)
• A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
• Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）
• Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
• Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
• Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
• A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
• Ketamine and Midazolam Infusions for CRPS: Feasibility Study
• Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and Sézary Syndrome
• Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
• Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
• Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
• Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
• Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
• Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
• Study of LQT-1213 on Dofetilide-Induced QTc Prolongation in Healthy Adult Subjects and Patients Diagnosed With Type 2 or 3 Long QT Syndrome
• Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment
• Tenapanor for the Treatment of Pediatric Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy
• De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS
• A Phase 1 Study of JSP191 (Briquilimab) in Subjects With LR-MDS
• A Phase 3 Study of VSA001 in Chinese Adults With Familial Chylomicronemia Syndrome
• The Danish Out-of-Hospital Cardiac Arrest Study
• Study of INV-202 in Patients With Obesity and Metabolic Syndrome
• Safety, Tolerability, and Efficacy of MatriPlax in Subjects With Acute Respiratory Distress Syndrome
• A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
• An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)
• Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
• Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
• A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
• To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
• The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome
• A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome
• Rituximab in the First Episode of Paediatric Nephrotic Syndrome
• Inhaled Sevoflurane for ARDS Prevention
• Vosoritide for Short Stature in Turner Syndrome
• Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
• Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome
• Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
• Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome
• A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
• The Effect of Escitalopram in PCOS
• A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
• An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
• imPROving Quality of LIFe In the Long COVID Patient
• Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT
• Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
• Ebastine Versus Mebeverine in IBS Patients
• A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome
• Allo HSCT Using RIC and PTCy for Hematological Diseases
• A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
• Effect of Metformin on Patients With Polycystic Ovary Syndrome
• Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study
• A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
• A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
• Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
• Prevention of Long Covid Syndrome
• Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
• Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome
• Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients
• Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
• Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome
• Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
• Bupivacaine or Radiofrequency for Shoulder Pain
• The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children
• Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV
• Platelet Sub-study of the Neomindset Trial
• Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
• Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation
• Rivaroxaban Combined With DAPT Versus DAPT Alone After Drug-coated Balloon Angioplasty
• Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome
• Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
• Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
• Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial
• Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
• A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
• Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
• Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome
• Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
• A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9
• Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea
• Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome
• Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
• A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)
• Effect of Weight Reduction and Aerobic Exercise on PMS Symptoms in Obese Females
• Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome
• BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
• A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
• Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome
• Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
• Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
• Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome
• Nasal Spray Study in Sjogren's Dry Eye Disease
• Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome
• Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients
• Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS
• A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome
• Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Study of NM8074 in Patients With aHUS
• Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS
• A Study With Imlifidase in Anti-GBM Disease
• Tacrolimus for Thrombocytopenia in SS
• A Phase II Study of Safety and Efficacy of AMX0035 in Adult Patients With Wolfram Syndrome
• Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome
• A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome
• Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
• Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis
• Effect of Stellate Ganglion Block on ME/CFS
• Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics
• Evaluation Study of the Intestinal Microbiota and Quality of Life in Patients Suffering From IBS Treated With Bifidice
• Therapies for Down Syndrome Regression Disorder
• Treatment of Ectopic Calcification in Fahr's Disease or Syndrome
• Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
• Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome
• Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
• Treatment With Metformin in Chinese Children With Alport Syndrome
• Phase 3 Study to Evaluate the Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
• Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)
• The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2
• Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
• Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of IBS-C
• Post-COVID-19 Chronic Fatigue Syndrome
• Capecitabine Induced Hand And Foot Syndrome
• Tocilizumab Acute Chest
• NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
• Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
• Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
• Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome
• Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
• Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
• Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
• Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
• Study of VYNT-0126 in the Treatment of Rett Syndrome in Adult Patients
• Dexmedetomidine Versus Triamcinolone Treatment in Carpal Tunnel Syndrome
• Randomized Controlled Clinical Stardy on Wumeiwan Jiawei Fang Use in Patients With Blepharospasm
• Phase II Trial of CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome
• TPN-101 in Aicardi-Goutières Syndrome (AGS)
• Anakinra in Dengue With Hyperinflammation ( AnaDen )
• Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome
• Botulinum Toxin A in Patients With Myofascial Pain Syndrome With and Without Zinc Supplementation
• Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome
• Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
• Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
• ASC - Autism Pilot Study
• Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Excess Blasts
• Part 1 - A Clinical Trial in Children and Adults With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
• Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
• Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
• Pitolisant in Refractory Restless Legs Syndrome
• 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Low Anterior Resection Syndrome(RALARS)
• Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)
• Hydrodissection Between Normal Saline and a Combination of Triamcinolone Acetonide, Normal Saline, and Lidocaine in CTS
• To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
• Comparison of Vaginal Hyaluronic Acid Treatment Over Autologous Platelet Rich Plasma Treatment for Genitourinary Syndrome of Menopause
• A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome.
• A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS
• Evaluating Navitoclax After Failure of Standard Treatments of Azacitidine or Decitabine and Venetoclax in Patients With Aggressive Myelodysplastic Syndrome
• Fenfluramine for Adult Dravet Patients
• Caudal Epidural Prolotherapy Versus Steroids in Failed Back Surgery Syndrome
• Study to Investigate CSL112 in Subjects With ACS
• Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial
• A Study of Paravertebral Block in Thoracic Outlet Syndrome
• A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)
• Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome
• Whiplash-induced Thoracic Outlet Syndrome Treated With Botulinum Toxin.
• Population Pharmacokinetics Of Bisoprolol in Egyptian Patients With ACS
• Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
• Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome
• Sublingual Apomorphine in Refractory Restless Legs Syndrome
• HEM1036 Phase 2 Study in Low Anterior Resection Syndrome
• A Muticenter Clinical Study of Chinese Herbal Compound TJAOA102 in Alleviating Menopausal Syndrome
• Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
• Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.
• Home Transcutaneous Electrical Acustimulation (TEA)
• Polypill in Acute Coronary Syndrome
• 5-HT3 Receptor Antagonist and Respiratory Drive in Patients With ARDS
• Budesonide Prophylaxis for Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation
• Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Recombinant Adeno-associated Virus Administration for Patients With Menkes Syndrome
• A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome
• Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males With Klinefelter Syndrome
• Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19 or PASC Syndrome
• Add-on Reparixin in Adult Patients With ARDS
• Local Injection of Steroid VS.Glucose 5% in Carpal Tunnel Syndrome
• Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)
• A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
• A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
• Atorvastatin Therapy on Xanthoma in Alagille Syndrome
• Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome
• Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
• Phase II Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome
• Ivabradine for Long-haul COVID With POTS Cohort
• Comparison of the Efficacy of Different Treatment Methods in Patients With Carpal Tunnel Syndrome
• Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome
• A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (
• Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A
• The Effect of Dihydroartemisinin in PCOS
• Polynucleotides Efficacy in the Genitourinary Syndrome of Menopause
• Lemborexant in Delayed Sleep Phase Syndrome
• Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Enzastaurin in Vascular Ehlers-Danlos Syndrome.
• FMT for Post-infectious IBS
• Fluoxetine Treatment of Depression in Down Syndrome
• Evolocumab Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
• Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
• A Randomized Single-Blind Controlled Trial Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
• Zinc Containing Vaginal Topical " Suppository "
• The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With Inflammatory Bowel Syndrome
• Masitinib for the Treatment of Severe Mast Cell Activation Syndrome
• A Study of ELX-02 in Patients With Alport Syndrome
• Study of AD981 Versus Placebo in Obesity Hypoventilation Syndrome
• ADX-629 Therapy for Sjogren-Larsson Syndrome
• SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
• A Study to Explore the Effect of Sepranolone in Tourette Syndrome
• Metabolomic Profile in Dry Eye Syndrome Patients.
• Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
• Low-dose Naltrexone for Post-COVID Fatigue Syndrome
• Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy
• Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
• Study on the Efficacy of Infiltration of Upper Cluneal Nerves in Chronic Pain Related to Cluneal Syndrome
• A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
• Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
• Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
• A Study of Fisetin to Treat Carpal Tunnel Syndrome
• Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
• BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome
• A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
• Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)
• Oxytocin for Hypermobile Ehlers-Danlos Syndrome
• Glucocorticoid Therapy for Acute Respiratory Distress Syndrome
• Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
• A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
• A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome
• Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
• Treating PCOS With Digital CBT vs. Metformin
• Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome
• Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome
• Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome
• Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome
• A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes
• A Study to Evaluate the Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
• Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D
• An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
• A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants
• A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndro
• Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
• Low Dose Naltrexone Use in Patients With POTS
• Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
• A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
• Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles as Early Goal Directed Therapy for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial
• The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis
• PreOperative Methylprednisolone on Thoracic Endovascular Repair for Reducing Post-implantation Syndrome (POMTEVAR)
• Urea Cream Prevention for Capecitabine Associated Hand Foot Syndrome
• Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome
• HRS-AKI Treatment With TIPS in Patients With Cirrhosis
• Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
• EVALUATION OF THE COMBINATION OF ANTIOXIDANTS METIONAC FOR THE MODULATION OF METABOLIC AND ENDOCRINE PARAMETERS IN PATIENTS WITH PCOS: A PROSPECTIVE RANDOMIZED STUDY
• Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V
• Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
• A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
• Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer
• Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A
• Management of Pain Associated With Failed Back Surgery Syndrome
• Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome
• Efficacy of Local Anesthetic and Ozone Injection in Patients With Myofascial Pain Syndrome
• A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
• Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
• A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children With Dup15q Syndrome
• SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
• A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome
• Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome
• "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome
• Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
• Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities
• Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
• Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome
• Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin
• Venetoclax Basket Trial for High Risk Hematologic Malignancies
• NB-001 in Children and Adolescents With 22q11 Deletion Syndrome
• A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome
• A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication Syndrome
• Dexmedetomidine Versus Hyalase Treatment of Carpal Tunnel Syndrome
• EA for BPS: An RCT and Study for Central Mechanism
• The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients
• Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome
• Thyroid Hormone Replacement in Patients With Septic Shock
• Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome
• Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis
• Comparison Study for Perimenopausal Syndrome With Chinese Herbal Medicine
• Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome
• COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)
• Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome
• Diagnosing Compartment Syndrome With SHAPE vs Elastography
• Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome
• Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
• Droperidol on Prevention of Cannabis Hyperemesis Syndrome
• Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS
• Comparison of the Efficacy of Prolotherapy Injection Therapy & Local Anesthetic Injection Therapy.
• Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients
• The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
• Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia
• Efficacy of Pentoxifylline and Alpha Lipoic Acid in PCOS Resistant to Clomiphene Citrate
• Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
• Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Subjects With SCN8A-DEE.
• Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
• Investigate the Efficacy and Safety of Carisbamate (YKP509) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
• An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)
• Long-term Pain Modulation by Intravenous Esketamine in CRPS
• A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome
• AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia
• Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
• Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
• Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome
• Ovarian Hyperstimulation Syndrome Using Calcium Infusion
• GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes
• Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial
• A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen
• Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? A Pilot Study
• Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
• Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
• Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948
• Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms
• A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
• A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
• The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome
• A Randomized Study of BPN14770 in Male Adolescents (Aged 12 to < 18 Years) With Fragile X Syndrome
• A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome
• Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS
• A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
• Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome
• Saccharomyces Cerevisiae for Irritable Bowel Syndrome
• A Phase I/II Trial of BMS-986253 in Myelodysplastic Syndromes
• Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory and That Expresses E-selectin Ligand on the Cell
• Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
• A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
• 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
• Ruxolitinib and Methylprednisolone as a First-line Treatment for Macrophage Activation Syndrome
• Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
• Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)
• Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)
• HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
• SCI-110 in the Treatment of Tourette Syndrome
• Less Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients
• AV-001 for Hospitalized Patients With COVID-19 Disease
• Metformin in Children With Fragile X Syndrome
• Explore the Effect of Gynostemma Pentaphyllum on Patients With Metabolic Syndrome
• Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study
• Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
• Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome （IBS)
• New Clinical End-points in Patients With Primary Sjögren's Syndrome
• Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
• Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS
• Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP)
• IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
• Homeopathic Treatment of Post-acute COVID-19 Syndrome
• Vitamin D Levels in Women With Polycystic Ovary Syndrome
• The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
• The Role of Neuromodulators in Refractory Functional Dyspepsia
• A Phase 2/3 Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader-Willi Syndrome
• Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy)
• Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome
• Amiloride in Nephrotic Syndrome
• Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome
• Efficacy of Letrozole Versus Clomiphene Citrate on Ovulation Induction in Patients With Polycystic Ovarian Syndrome
• EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children With Lennox Gastaut Syndrome.
• Cyclic Vomiting: Droperidol
• A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid L
• Burning Mouth Syndrome - New Diagnostic Criteria and Treatment
• Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome
• Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome
• Radiofrequency, Perineural Injection, Idiopathic Carpal Tunnel Syndrome
• Vortioxetine for Post-Covid-19 Syndrome
• Postinfectious Irritable Bowel Syndrome and Gelsectan
• Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
• Efficacy and Safety of Broncho-Vaxom in the First Episode of Pediatric Idiopathic Nephrotic Syndrome
• PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population
• The Effect of Melatonin in Patients With Low Anterior Resection Syndrome
• Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
• Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
• Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
• Single Blind Study of Ergoloid Mesylates, 5-HTP and the Combination in Adult Males With Fragile X Syndrome
• A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
• A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Who Are 4 Months or Older
• An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)
• An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)
• AT1001 for the Treatment of COVID-19 Related MIS-C
• The BeLimumab Antiphospholipid Syndrome Trial (BLAST)
• Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection
• Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
• [KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome
• Efficacy and Safety of Baricitinib in Sjogren's Syndrome
• An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome
• ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome
• Fish Oil (Omega 3 ) in Sjogren's Syndrome
• A Study to Evaluate the Safety and Effect of STC314 Injection Continuous Infusion in Subjects With Acute Respiratory Distress Syndrome
• A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.
• Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2
• Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes
• Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
• A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection
• The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome
• WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?
• VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.
• An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
• Cyclosporine vs Steroids in DRESS
• A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
• A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes
• Vitamin E Efficacy in HI/HA
• Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety
• Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
• The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
• Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
• A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)
• Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
• A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
• Effects of Gum Arabic on Metabolic Syndrome Parameters in Postmenopausal Women
• Clinical Study of Cannabidiol in Children and Adolescents With Fragile X Syndrome
• NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
• Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
• CANA/Met in Non-diabetic Women With PCOS
• 1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon
• Study of Varespladib in Patients Hospitalized With Severe COVID-19
• A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
• Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
• Metabolic Balance Study of Apraglutide in Patients With SBS-IF and Colon-in-Continuity
• Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome
• Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
• Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19
• A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.
• Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes
• Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome
• Mono Antiplatelet and Colchicine Therapy
• A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101
• Myofascial Pain Syndrome and Dextrose Prolotherapy
• A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome
• Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome
• Probiotic in Dry Eye Syndromes
• A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome
• Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)
• MonotherApy of Low-does TicagrElor After Percutaneous Coronary Intervention
• Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
• Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
• A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients
• Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetocl
• Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
• Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
• Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations
• A Trial of AK117 (Anti-CD47) in Patients With Myelodysplastic Syndrome
• Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
• MIS-C Comparative Effectiveness Study
• CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome
• Effects of Myo-inositol in Women With Polycystic Ovary Syndrome
• FHD-286 in Subjects With Advanced Hematologic Malignancies
• Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome
• Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy
• Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
• A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
• Safety and Efficacy of Esmketamine Versus Dexmedetomidine
• Prevention of Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.
• GLP-1 RAs in Patients With Polycystic Ovarian Syndrome (PCOS)
• Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1
• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome
• Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
• Safety Study of Inhaled Carbon Monoxide to Treat Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
• Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)
• Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
• Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell Transplantation in Patients With AML (Acute Myeloid Leukemia) and Myelodysplastic Syndromes
• Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH.
• Personalized Spacing of Eculizumab Infusions Based on Therapeutic Pharmacological Monitoring (EspacECU)
• Iron Sucrose in Patients With Iron Deficiency and POTS
• Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin
• Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
• Colchine for the Stability of Coronary Plaque in Acute Coronary Syndrome(COLOCT)
• A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients
• Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome
• Rifaximin Therapy vs Low FODMAP Diet In IBS
• DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia
• CEQUA for Sjogren's Syndrome Dry Eye
• Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine
• The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
• A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
• Investigation of Sulindac in Male Fragile X Syndrome Patients Aged 13-40
• Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
• Role of Montelukast in Preventing Relapse in Childhood Idiopathic Nephrotic Syndrome
• Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome
• Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome
• A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants
• Clinical Study on Wuling Powder in Treating Metabolic Syndrome of Spleen Deficiency and Dampness
• Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS
• Buspirone Treatment of Anxiety in Williams Syndrome
• Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (CPX-351) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
• The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
• Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
• SY-1425 Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome
• Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence
• Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
• Pimavanserin Treatment in TS
• Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
• N-acetylcysteine for Primary Sjögren's Syndrome
• Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome
• Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome
• Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome
• Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
• Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome
• Open-Label Extension Study of Trofinetide for Rett Syndrome
• Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects
• Safety and Efficiency of γ9δ2 T Cell Against Post-transplant Acute Leukemia/Myelodysplastic Syndrome Relapse
• Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders
• Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19
• The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome
• A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
• DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
• the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome
• A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)
• Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
• Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
• Peripheral Nerve Injections for CRPS
• Roflumilast in ARDS
• ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion
• An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome
• Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
• Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
• Rho Kinase (ROCK) Inhibitor in Tauopathies - 1
• Inhibition of Reverse Transcription in Aicardi-Goutières Syndrome
• A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).
• Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
• Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
• Complement Regulation to Undo Systemic Harm in Preeclampsia
• MT1002 Phase II Study in ACS Patients With PCI
• Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome
• A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome
• Role of Alprazolam in the Management of Acute Coronary Syndrome
• Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome
• Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl
• Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation
• Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II
• PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
• LYell SYndrome MEsenchymal Stromal Cells Treatment
• Venetoclax, Busulfan, Cladribine, and Fludarabine for the Treatment of High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia
• Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial
• TCM Syndrome Differentiation Treatment on Discharged Elderly Patients With CAP
• Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome
• SGLT2 Inhibitors in Patients With Polycystic Ovarian Syndrome
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome
• Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Rosuvastatin) I
• Adrenaline for the Treatment of No-Reflow in Normotensive Patients
• Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
• A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS)
• Anal Dilatation Plus Probiotics Before Ileostomy Reduction for Low Anterior Resection Syndrome
• A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
• Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome
• L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles
• Midodrine as Novel Treatment of Post-Cardiopulmonary Bypass Vasoplegic Syndrome
• Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
• The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye
• BROKEN-SWEDEHEART-Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome
• Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19
• Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
• Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
• VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
• Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
• Effectiveness of Ketamine Administered by Mesotherapy in Complex Regional Pain Syndrome Type 1 (CRPS1)
• Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup
• Effects of Methylphenidate on Brain and Cognition in 22q11 Deletion Syndrome
• A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19
• Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
• APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS)
• IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
• Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth
• Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
• Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2
• Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.
• Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
• Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest
• A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome
• A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS
• Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
• A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
• SILtuximab in Viral ARds (SILVAR) Study
• Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome
• Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome
• Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome
• Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder
• Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build
• A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
• Open-label Trial of IVIG in Children With PANS
• Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.
• A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome
• Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients
• Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
• Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
• PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE
• Pregabalin Treatment for Trigger Points
• Effect of Ciclosporin Eyedrops on Sjögren Syndrome
• Probiotic Intervention in PCOS
• Acetylated Natural Nucleotides in Treating Hand-foot Syndrome
• HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome
• Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
• The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman Syndrome
• Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers
• Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Idiopathic Nephrotic Syndrome.
• To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma.
• An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.
• Mutation-specific Therapy for the Long QT Syndrome
• Corticosteroid and Repeated Dextrose Hydro-dissection for Carpal Tunnel Syndrome Patients
• Letrozole in Patients With Hepatopulmonary Syndrome
• Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome
• Probiotics and Irritable Bowel Syndrome
• Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)
• A Study of AKCEA-APOCIII-LRx Administered to Patients With Familial Chylomicronemia Syndrome (FCS)
• Pharmacodynamic Evaluation of Antiplatelet Effect of Swallowing Versus Chewing Ticagrelor in Patients With Acute Coronary Syndrome
• Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19
• BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome
• Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.
• Efficacy and Safety of Rifaximin With NAC in IBS-D
• Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin
• Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients
• Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
• A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause
• Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
• Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome
• Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome
• A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19
• Study of Initial Steroid Treatment in Young Children With Nephrotic Syndrome
• Randomized Trial Evaluating Mycophenolate Mofetil in Children With Nephrotic Syndrome After Rituximab Treatment
• Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)
• Comparison of Ovulation Induction Cycle Outcomes Between Early and Late Dose Increments for Low Dose Gonadotropin Step-up Protocol Among Infertile Women Diagnosed With Polycystic Ovary Syndrome: Prospective Randomised Trial
• Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients
• Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)
• Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome
• A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS
• A Comparison of Ultrasound-guided Steroid Injection With Wrist Splint in Carpal Tunnel Syndrome
• Phase I Study of Progerinin in Healthy Volunteers
• Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study
• LSG in Obese Patients Polycystic Ovary Syndrome
• Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19)
• Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome
• Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.
• Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome
• Rituximab for Idiopathic Nephrotic Syndrome
• CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations
• Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution for the Treatment of Motoric Cognitive Risk Syndrome
• Azacitidine, Venetoclax, and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome
• Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
• Safety and Efficacy of IBI188 With Azacitidine in Newly Diagnosed Higher Risk MDS
• Global Growth Hormone Study in Adults With Prader-Willi Syndrome
• Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
• Head Yuanshi Dian Therapy in Burning Mouth Syndrome
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
• Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
• Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19
• A Study to Evaluate the Efficacy, Pharmacokinetics and Safety of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) in Chinese and Japanese Subjects With Ring Siderobl
• Interactions of Medicine and Exercise With Meal Timing
• Efficacy and Safety of Itolizumab in COVID-19 Complications
• Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome
• EPX-100 (Clemizole Hydrochloride) as Add-on Therapy to Control Convulsive Seizures in Patients With Dravet Syndrome
• The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome
• Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)
• Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)
• Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome
• Low-dose Naltrexone for Bladder Pain Syndrome
• Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
• Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser
• An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome
• What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
• Ultrasound-guided PRP Versus Steroid Injections in Management of Carpal Tunnel Syndrome
• Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
• A Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of RO7248824 In Participants With Angelman Syndrome
• A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
• A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)
• This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Diffi
• Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
• Comparison of Non-Surgical Treatment Options for Chronic Exertional Compartment Syndrome (CECS)
• Effects of Non-invasive Ventilation With Helium-oxygen Mixture in Premature Infants With Respiratory Distress Syndrome
• LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
• Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome
• Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
• Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
• Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
• Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome
• Treatment of POEMS Syndrome With Daratumumab
• A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)
• The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.
• GnRH Therapy on Cognition in Down Syndrome
• Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
• Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19
• COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111
• Low-Dose Ketamine in Children With ADNP Syndrome
• HU007 Eye Drops in Patients With Dry Eye Syndrome
• Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
• Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome
• Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
• Proof of Concept Study in Patients With Short Bowel Syndrome
• A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes
• A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
• Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19
• CLAG-M Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
• Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS
• Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome
• MSCs in COVID-19 ARDS
• Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome
• Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
• Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
• Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
• Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide
• PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial
• Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection
• Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome
• A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
• Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
• Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
• Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
• Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)
• Atomoxetine in Patients With Tourette's Syndrome
• A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
• Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response
• Polyvalent Immunoglobulin in COVID-19 Related ARds
• Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19
• Comparison of Ultrasound-guided Corticosteroid Injection Versus Corticosteroid Injection and Hydrodissection for Carpal Tunnel Syndrome
• Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS)
• Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition
• Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19
• Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
• Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
• Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation
• Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease
• Treatment of SARS Caused by COVID-19 With Ruxolitinib
• Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
• Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.
• Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
• Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
• LOD vs Gn in Anovulatory PCOs Resistant to First Line Agents
• Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
• Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2
• The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
• A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)
• Effect of a Probiotic Formula on Reducing SIBO in IBS Patients
• ARQ 092 (Miransertib) in Proteus Syndrome
• Surfactant Nebulization for the Early Aeration of the Preterm Lung
• Novel Clinical Target in Fragile X Syndrome
• IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
• Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
• Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl Syndrome
• Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
• Neuroimaging GABA Physiology in Fragile X Syndrome
• Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
• A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients
• A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior Patients
• Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19
• ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome
• Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
• Different Does of Acupuncture on Premenstrual Syndrome Efficacy Analysis
• Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.
• Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome
• Oral Gabapentin in the Treatment of Carpal Tunnel Syndrome
• MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT
• Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome
• Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome
• Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
• Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
• Dose Escalation/ Expansion Trial of CA-4948 as Monotherapy and in Combination With Azacitidine or Venetoclax in Patients With AML or MDS
• A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome
• HYDROxychloroquine in Syndrome Primary AntiPhospholipid
• Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?
• CPX-351 in Higher Risk Myelodysplastic Syndromes
• The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme
• Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2)
• A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Trans
• Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
• A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
• A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
• Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS
• A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS, CMML, or AML
• Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
• A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
• An Open-label Extension Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
• Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia
• Tofacitinib for Immune Skin Conditions in Down Syndrome
• SX-682 Treatment in Subjects With Myelodysplastic Syndrome Who Had Disease Progression or Are Intolerant to Prior Therapy
• Lidocaine Patch 1.8% for Moderate to Severe Pain From Carpal Tunnel Syndrome
• A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome
• A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY
• Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
• Canakinumab and Azacitidine for the Treatment of Low or Intermediate Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia
• SEvoflurane for Sedation in ARds
• Greater Trochanteric Pain Syndrome: Efficacy of Ultrasound Guided Platelet-rich Plasma vs Needle Tenotomy.
• Off-the-shelf Third Party Expanded NK Cells in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Evaluating Treatment of ADHD in Children With Down Syndrome
• Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
• Rectal Versus Oral Diazepam Administration in the Treatment of Levator Ani Syndrome
• Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
• Dapagliflozin Efficacy and Action in PCOS
• Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome
• PK and Safety of SI-722 in IC/BPS
• Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome
• A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndro
• Medium vs Low Oxygen Threshold for the Surfactant Administration
• Efficacy and Safety of Pirfenidone Treatment in HPS-ILD
• A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
• Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention
• Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine
• 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
• Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants
• Effectiveness of Supervised Exercise Program in Subacromial Impingement Syndrome
• Crossover Study of Propranolol vs Ivabradine in POTS
• Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
• Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)
• Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124
• Treatment Strategies in CHS
• Novel Form of Acquired Long QT Syndrome
• Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
• Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
• RCT for Pregabalin in Restless Legs Syndrome in South Korea
• Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome
• Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome
• CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML
• Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients
• A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
• Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome
• A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo
• Combined Effect of Insulin and Sodium Hyaluronate Injection Guided by Ultrasound in Carpal Tunnel Syndrome
• Metformin in Patients With Fragile X
• Autonomic Determinants of POTS - Pilot 2
• Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
• Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation
• Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
• Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS
• A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome
• Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
• Study of Safety and Immunogenicity of BVRS-GamVac-Combi
• EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders
• Clinical and Basic Research on the Treatment of Polycystic Ovary Syndrome
• Pain Reduction Produced by Different Treatments in Carpal Tunnel Syndrome
• OPTImal Management of Antithrombotic Agents: OPTIMA-5
• Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS)
• Medications for Obstructive Sleep Apnea In Children With Down Syndrome
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
• Detecting Compartment Syndrome Pain in the Presence of Regional Anesthesia in Healthy Volunteers
• A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome.
• A Study of OV101 in Individuals With Angelman Syndrome (AS)
• CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome
• The Use of Eculizumab in HELLP Syndrome
• Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome
• Sirolimus for Cowden Syndrome With Colon Polyposis
• Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome
• Comparison of Transanal Irrigation and Glycerol Suppositories in Treatment of Low Anterior Resection Syndrome
• An Open-Label Study of DCCR Tablet in Patients With PWS
• Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334
• Cord Blood Transplant With OTS for the Treatment of HIV Positive Hematologic Cancers
• Metoprolol for the Treatment of Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
• Vitamin D and Pregnancy Outcome in PCOS Patients
• Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D
• Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.
• A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy
• Follicular Synchronization in PCOS Patients Undergoing ICSI
• Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome
• Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome
• Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
• Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
• Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome
• Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
• Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)
• Autonomic Determinants of POTS - Pilot1
• Angiotensin 2 for Hepatorenal Syndrome
• Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome
• Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• A Study of the Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome
• Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.
• Olorinab in IBS-C and IBS-D
• A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
• Open-Label, Extension Trial to Demonstrate the Effectiveness and Safety of L-CsA Plus Standard of Care in the Treatment of BOS in Patients Post Single or Double Lung Transplant
• A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome
• A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)
• Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
• A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 M
• Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
• Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome
• DUAL Antithrombotic Therapy in Patients With AF and ACS
• Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome
• Sevoflurane PharmacokInetics in ARDS
• Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin
• PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
• RVY120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
• The Effect of Theraworx Foam in Carpal Tunnel Syndrome
• Dextrose, Corticosteroids and Surgical Release in Carpal Tunnel Syndrome
• ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
• Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome
• Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• Comparison of Probiotics, Metformin & Their Combination Therapy in the Treatment of PCOS
• Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
• Growth Hormone Treatment in Children With Phelan McDermid Syndrome
• Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)
• Symptom Clusters in Children With Exacerbation-prone Asthma
• Platelet Rich Plasma in Carpal Tunnel Syndrome
• Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS
• Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome
• Burosumab for CSHS
• A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome
• Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS)
• Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome
• Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation
• Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome
• A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact
• Pembrolizumab and Decitabine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory
• Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients
• Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant
• CPX-351 Therapy for MDS After Hypomethylating Agent Failure
• Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
• Levocarnitine for Dry Eye in Sjogren's Syndrome
• Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
• A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).
• The Effect of Cinnamon on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome; a Pilot Study
• Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
• A Study of Imlifidase in Patients With Guillain-Barré Syndrome
• ANAVEX2-73 Study in Patients With Rett Syndrome
• HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
• A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
• ONC 201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant
• A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
• APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant
• CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome
• PRGN-3006 Adoptive Cellular Therapy for Relapsed or Refractory AML or High Risk MDS
• Fecal Microbial Transplant (FMT) for Sjogrens Syndrome
• Botanical Tincture for Symptoms of Irritable Bowel Syndrome
• A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)
• Botox for the Treatment of Chronic Exertional Compartment Syndrome
• JAK Inhibitor Treatment in AGS
• Medication Treatment for Opioid Use Disorder in Expectant Mothers
• A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
• A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
• Clinical Trial Scheme of Xinnaoning Capsule
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
• Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren's Syndrome
• An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion
• A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome
• Compare Efficacy and Safety of Repeated Courses of Rituximab to That of Maintenance Mycophenolate Mofetil Following Single Course of Rituximab Among Children With Steroid Dependent Nephrotic Syndrome
• CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
• Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma
• A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease
• A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
• A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS
• An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
• Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS
• The Efficacy of Different Doses of Acupuncture in Dysmenorrhea
• Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome
• Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES
• Steroid Sensitive Nephrotic Syndrome in Children
• Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
• Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome
• Umbilical Cord Blood Transfusion in Progeria Syndrome
• Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
• Inositol Supplementation to Treat PCOS (INSUPP-PCOS)
• A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
• Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
• Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
• Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
• CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
• A Trial of TD0019 in Treatment of Cervical Scapulohumeral Syndrome
• Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
• The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
• Probiotics as a Prophylaxis to Prevent Clinical Manifestations of Oral Candidosis in Patients With Sjogren's Syndrome
• A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation
• Study of TOP1630 for Dry Eye Syndrome
• The MUFFIN-PTS Trial
• Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
• PRGN-3006 Adoptive Cellular Therapy Relapsed or Refractory CD33-Positive AML or High Risk MDS
• International Clinical Study of Zhizhu Kuanzhong Capsule
• Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes
• Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants
• Terlipressin Infusion Alone Vs Terlipressin With Noradrenaline Infusion In The Treatment of Hepatorenal Syndrome Type 1
• Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome
• Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis Patients
• A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
• TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
• A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
• Effect of Food on Blood Levels of ASTX727
• Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
• DIalysis Symptom COntrol-Restless Legs Syndrome Trial
• Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
• The Effect Of Vitamin D Replacement Therapy On Serum Leptin And Follicular Growth Pattern In Women With Resistant Polycystic Ovary
• Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
• Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation
• Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
• Vitamin B12 for Carpal Tunnel Syndrome
• Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
• Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation
• Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
• Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial
• Montelukast for Prevention & Treatment of OHSS
• The Effect of Calcium and Vitamin D Supplements on Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Patients
• Comparison of the Efficacy of Corticosteroid Injection and ESWT in Patients With CTS
• Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
• Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
• A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
• Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
• MANP in Hypertension and Metabolic Syndrome
• Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
• Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
• The Effect of Cinnamon on Ovulation Induction in Women With Polycystic Ovary Syndrome
• Erythropoietin in Hemolytic Uremic Syndrome
• Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS
• Norepinephrine Boluses in Liver Transplantation
• New Application of Sequential in Vitro Muturation System for Infertility Patients With Polycystic Ovary Syndrome
• Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease
• AZD6738 for Patients With Progressive MDS or CMML
• Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation
• Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome
• Selective Microbiota Transplantation for Tourette's Syndrome
• Study of SkQ1 as Treatment for Dry-eye Syndrome
• Efficacy and Safety of SYN-010 in IBS-C
• Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome
• Pupil Dilation for Treatment of IFIS
• Study of ANAVEX2-73 in Patients With Rett Syndrome
• Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin
• Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
• Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant
• Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome
• Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome
• ABI-009 (Nab-sirolimus) in Patients With Genetically-confirmed Leigh or Leigh-like Syndrome
• Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
• A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes
• Allopurinol in Acute Coronary Syndrome
• IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
• Local Injection of Ozone Versus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma Patients
• Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or High-Risk Myeloproliferative Neoplasm
• Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
• Vitamin B12a Vasoplegic Syndrome
• Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome
• Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome
• Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
• A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause
• Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.
• Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.
• Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome
• Metformin in Children and Adults With Fragile X Syndrome
• Smith-Lemli-Opitz Syndrome and Cholic Acid
• Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants
• AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis
• Efficacy and Safety Trial of Sodium Valproate, in Paediatric and Adult Patients With Wolfram Syndrome
• Electromyographic Study for the Help and Guidance of BoNTA Administration in the Treatment of Chronic Pelvic Floor Pain
• Open-Label Extension Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
• Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility
• Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients
• Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: A Dimensional Approach
• Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)
• Inflammation Reduction by TREhalose AdminisTration
• Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies
• A Study of OV101 in Individuals With Fragile X Syndrome
• A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
• Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome
• A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)
• Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
• RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
• Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
• The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
• Efficacy of Vit E in PCOS Resistant to Clomiphene Citrate
• Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome
• Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI)
• 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
• Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome
• Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
• Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
• BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies
• Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
• The Gut Microbiome in Women With Polycystic Ovary Syndrome
• Amla on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• A Study to Evaluate Ketamine for the Treatment of Rett Syndrome
• Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI
• Botulinum Toxin Injection for Functional Popliteal Artery Entrapment Syndrome
• Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
• Adding L-Carnitine to Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome
• The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
• A Study of INCB050465 in Primary Sjögren's Syndrome
• A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS
• Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
• Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Formula） Intervention to Polycystic Ovary Syndrome
• Open-label Treatment in Cushing's Syndrome
• "Efficacy of Botulinum Toxin Injection in Reducing Limb Pain in Patients With Complex Regional Pain Syndrome"
• Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
• Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• Fecal Microbiota Transplantation for Irritable Bowel Syndrome
• Venetoclax Added to Fludarabine + Busulfan Prior to Transplant for AML, MDS, and MDS/MPN
• Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
• Comparison Between Rebamipide 2% Versus Autologous Serum
• Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
• Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
• Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults
• Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
• Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
• Midodrine in Hepatopulmonary Syndrome
• Biological Predictive Factors of Response to ESA in Low Risk MDS Patients
• Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)
• An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004
• Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome
• Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
• Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
• Quality of Life and Sjögren Syndrome
• Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome
• A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
• Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome
• A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)
• A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
• Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents
• Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
• Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
• Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)
• Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome
• Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome
• Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome
• TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome
• A Polypill for Secondary Prevention of Ischemic Heart Disease
• Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome
• Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
• Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
• Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation
• Trigonal vs Non Trigonal Botox Injection in OAB.
• Efficacy and Safety of Intravenous Neridronic Acid in CRPS
• Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
• Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
• Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
• A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes
• Evolocumab in Acute Coronary Syndrome
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
• Caduet and TLC Intervention in Metabolic Syndrome
• IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
• Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
• Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome
• Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
• Study of SyB C-1101 in Patients With Myelodysplastic Syndrome
• Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
• AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
• Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement
• Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
• Endometrial Thickness and Subendometrial Vascularity in Anovulatory Polycystic Ovarian Syndrome Patients Treated by Metformin
• A Study of FF-10501-01 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome
• Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
• Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
• A Trial of Metformin in Individuals With Fragile X Syndrome
• Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Factors - A Study Protocol for a Double-blind, Randomised, Multi-center, Placebo-controlled Clinical Trial
• L-Carnitine and Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome
• Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
• A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol
• Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS
• Clinical Trial Comparing Two Bladder Instillations for IC/BPS
• Rifaximin on Visceral Hypersensitivity
• ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS
• Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
• Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS
• A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Patients With Prader-Willi Syndrome
• Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome
• Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
• Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents
• iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
• RESET Trial - Part 1 (Followed by Reset Trial - Part 2) - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)
• Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
• Eluxadoline Bile Acid Malabsorption (BAM) Study
• A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
• Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome
• Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole
• Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
• Sjögren's Syndrome Is Associated With Meibomian Gland Dysfunction
• A Phase Ib/IIa Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
• a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics
• Prophylaxis Versus Treatment for TURP Syndrome.
• Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
• Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support
• A Multi-Center Study on the Metoprolol Optimal Dosing Pathway of Metoprolol Application in Chinese Patients With Acute Coronary Syndrome
• RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
• ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children
• Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency
• Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.
• Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome
• A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)
• CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS
• Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
• Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
• TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
• CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
• A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)
• Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
• Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome
• Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI
• The Volume Effect of Nerve Hydrodissection for Carpal Tunnel Syndrome
• Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
• Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir
• A Study of RG-012 in Subjects With Alport Syndrome
• Kinetics of Surfactant Proteins, Phosphatidylcholine and Body Water in Intensive Care Unit (ICU)
• A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS
• Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome
• Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)
• Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients
• Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome
• DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
• TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
• PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)
• DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
• Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome
• A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome
• Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients
• Pharmacokinetics of Tacrolimus in Children
• N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome
• Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
• Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome
• Botulinum for Chronic Exertional Compartment Syndrome
• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
• Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2
• Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
• Effect of Metformin and Probiotics in Reproductive-aged Patients With Polycystic Ovary Syndrome
• Myelodysplastic Syndrome--CDA-2 Hematological Improvement National Affirmation Study
• Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
• HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
• Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome
• Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
• Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients
• Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS
• A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHL
• Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML
• A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
• Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome
• A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome
• Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
• Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)
• Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome
• A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome
• Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome
• Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome
• EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
• ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
• A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis
• A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
• Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion
• A Study of GLWL-01 in Patients With Prader-Willi Syndrome
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
• A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302
• Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies
• Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS
• Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study
• Nivolumab With Chemotherapy in Refractory MDS
• Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
• Berberine Treat Metabolic Syndrome in Schizophrenia
• Multi-strain Probiotic in the Management of IBS-D
• Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
• A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome
• Safety and Efficacy of Cannabis in Tourette Syndrome
• Intranasal Oxytocin for Infants With Prader-Willi Syndrome
• A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)
• Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
• Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)
• Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction
• Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
• Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults With Acute Myeloid Leukemia
• Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)
• Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles
• Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
• Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
• Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Patients.
• Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery
• Smoking Cessation After Acute Coronary Syndrome
• Milrinone Versus Dobutamine in Critically Ill Patients
• Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS
• Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome
• Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
• Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration
• Preventive Application of GnRH Antagonist on Early OHSS
• Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS
• Impact of Traditional Chinese Medicine on the Gut Microbiota-dependent Trimethylamine N-oxide
• Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS)
• Platelet Rich Plasma for Carpal Tunnel Syndrome
• Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
• Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome
• Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)
• Hyaluronic Acid Hydro-dissection Use in Idiopathic Carpal Tunnel Syndrome Guided by Ultrasonic Study
• Median Nerve Hydro-dissection Using Single Injection of Hyalase as a Novel Treatment of Carpal Tunnel Syndrome
• A Study of ONO-7475 in Patients With Acute Leukemias
• IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome
• The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients
• A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome
• Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
• Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome
• A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes
• The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
• Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
• Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)
• Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent
• Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients
• Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma
• Prednisolone Trial in Children Younger Than 4 Years
• An Initial Study of AZD7325 in Adults With Fragile X Syndrome
• Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)
• Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence Syndrome
• High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
• 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
• Polyprenols (Ropren) in Acute Coronary Syndrome
• Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
• Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
• Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years
• Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome
• SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
• Iloprost in Acute Respiratory Distress Syndrome
• Single Dose Pharmacokinetic (PK) Study
• PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma
• Small Doses of Pituitrin Versus Norepinephrine for the Management of Vasoplegic Syndrome in Patients After Cardiac Surgery
• Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A
• Renal Anhydramnios Fetal Therapy
• Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome
• AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
• Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D
• A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome
• The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels
• Use of Pancreatic Enzymes in Short Bowel Syndrome
• Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
• Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002)
• Azacitidine and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome
• Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
• The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome.
• Prevention of Ulinastatin on Acute Respiratory Distress Syndrome (ARDS)
• Safety and Efficacy of TOP1630 for Dry Eye Syndrome
• Study to Assess the Effect of Metformin Supplementation on IVF Outcome in Patients With Polycystic Ovarian Syndrome.
• Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.
• Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome
• Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS
• Corticosteroid Injection in Carpal Tunnel Syndrome
• Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
• Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
• "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children"
• Daratumumab in Subjects With Relapsed/Refractory Acute Myelogenous Leukemia or High-Risk Myelodysplastic Syndrome
• Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
• Safety and Efficacy of BRM421 for Dry Eye Syndrome
• Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome
• Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?
• A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS
• Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome
• A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
• Pyrimethamine for Intermediate/High-risk Myelodysplastic Syndromes (MDS)
• A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome
• A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
• A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
• A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH
• Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome
• Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
• Tocilizumab in Patients With Schnitzler's Syndrome
• Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)
• Treatment Development of Triheptanoin (G1D)
• MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)
• Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome
• A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)
• Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia
• Exercise Training Effects on Metabolic Syndrome: Interactions With Medication
• A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
• Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach.
• VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, or T-cell Lymphoma
• A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome
• Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
• Gabapentin for Alcohol Withdrawal Syndrome
• Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulati
• Empagliflozin vs Metformin in PCOS
• A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome
• Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
• Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot Study
• Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome
• A Study in Adults and Adolescents With Angelman Syndrome
• CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
• RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
• The Effect of Hydrodissection for Carpal Tunnel Syndrome
• The Effect of Perineural Injection Therapy Versus Steroid in Patients With Carpal Tunnel Syndrome
• Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
• NATIENS: Optimal Management and Mechanisms of SJS/TEN
• Platelet Rich Plasma and Hydrodissection for Carpal Tunnel Syndrome
• Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
• Berberine as Adjuvant Treatment for Schizophrenia Patients
• Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support
• Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
• Ethosuximide to Treat IBS
• Safety of Intravenous Neridronic Acid in CRPS
• The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients
• Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)
• Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS
• Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
• A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome
• A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)
• Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
• Immune Effects of Low-dose Naltrexone in ME/CFS
• Botulinum Toxin in Burning Mouth Syndrome
• Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome
• Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
• Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use
• The Effect on EPCs by Statin Loading in "All Comers" With an ACS
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
• Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
• Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
• Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
• Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome
• A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)
• Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
• Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
• Clinical Trial for Asses the Safety and Efficacy of Vitamin C and Vitamin E in Combination Versus Placebo for Treating Cognitive and Behavior Disorder in Children With Fragile X Syndrome
• A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
• Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome
• Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents
• Mechanisms of Cerebrovascular Control
• Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed
• Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
• Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q
• A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Sy
• Rivaroxaban for Patients With Antiphospholipid Syndrome
• Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome
• Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
• AFQ056 for Language Learning in Children With FXS
• Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome
• Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome
• Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
• Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes
• Impact of Metformin on In Vitro Fertilization Outcomes in Overweight and Obese PCOS Women
• Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
• Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs
• Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome
• Valproic Acid for Idiopathic Nephrotic Syndrome
• Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
• The Safety and Dose Response Relationship of Ulinastatin for Acute Respiratory Distress Syndrome(ARDS)
• Acute Coronary Syndrome Sri Lanka Audit Project
• Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
• Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome
• Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)
• Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
• Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome
• Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome
• Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome
• The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS
• MLE4901 vs. Placebo for the Treatment of PCOS
• Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
• Safety and Efficacy Study in Infant With SBS
• Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
• Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI
• Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
• Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
• Study of Lademirsen (SAR339375) in Patients With Alport Syndrome
• Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
• HL2351 CAPS Phase II Study
• Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome
• A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes
• A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
• Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome
• Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome
• Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome
• Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
• A Study of H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
• A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C
• Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
• A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)
• Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
• Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome
• Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)
• A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
• A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome
• Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
• Does The Surfactant Administration by Aerosolization Effective?
• An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
• TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
• Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea
• Corticosteroid Mediates Acute Respiratory Distress Syndrome
• Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children
• The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy
• Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
• Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks
• Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome
• The Effect of Perineural Injection Therapy in Patients With Carpal Tunnel Syndrome
• A Biomarker-Directed Phase 2 Trial of SY-1425 in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
• Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
• Combined Letrozole and Clomid in Women With Infertility and PCOS
• Metformin for Prevention Gestational Diabetes in Pregnant Women With Polycystic Ovarian Syndrome
• Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS
• Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
• L-Citrulline in Patients With Post-Polio Syndrome
• Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer
• Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
• Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg
• Optimum Thiamine Intervention (OpTIn) Trial
• Human Chorionic Gonadotropin Stimulation Effects on Steroidogenesis in Men With Klinefelter Syndrome
• Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
• A Study of Pevonedistat in Adult East Asian Participants
• Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
• Tipifarnib in Subjects With Myelodysplastic Syndromes
• A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)
• Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome
• Study to Evaluate the Efficacy and Safety of CKD-350
• Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
• An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)
• NAC in CC Resistant PCOS After LOD
• Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
• Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome
• A Study in Preterm Neonates With RDS to Compare CUROSURF® Administration Through LISA and Conventional Administration
• Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1
• Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity
• Rhupus Syndrome and Efficacy of Etanercept Treatment
• Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS)
• Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients
• Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
• Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
• Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients
• A Trial of Doxycycline in Renal Disease
• CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.
• Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
• Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
• Effects of PG2 on Fatigue-Related Symptom Clusters
• Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome
• Study of PRO 140 for Prophylaxis of Acute GVHD in Patients Undergoing RIC Allogenic Stem-Cell Transplantaton
• A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS
• Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard Umbilical Cord Blood in Patients With Leukemia, Lymphoma, and Myelodysplastic Syndrome (MDS)
• The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome
• Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT
• Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma
• A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C
• Autoimmune Basis for Postural Tachycardia Syndrome
• Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in Women
• A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
• UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
• Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes
• Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
• Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome
• Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery
• Stopping Benzodiazepines and Related Molecules Among Elderly Living in Residential Institutions
• A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
• Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome
• Liberal Oxygenation Versus Conservative Oxygenation in ARDS
• Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
• Efficacy of Combined Ultrasound Guided Steroid Injection and Splinting in Patients With Carpal Tunnel Syndrome
• Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS
• Long Term Safety Study of Plecanatide
• A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome
• Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin
• Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome
• Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
• Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
• Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome
• The Letrozole Administration During Luteal Phase
• A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
• Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant
• A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
• Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
• Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome
• Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome
• Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome
• MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial
• Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome
• A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
• POTS Adrenergic Ab (CIHR Aims #1&2)
• Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome
• Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS
• Platelet-rich Plasma (PRP) Injection for Treating Shoulder Subacromial Impingement Syndrome
• Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
• WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
• A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy.
• Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome
• Allo HSCT Using RIC for Hematological Diseases
• Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia
• Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
• The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome
• The Effect of Shigyakusan Used for IBS and MUPS Diagnosed by Abdominal N Line Tenderness
• The Use of DPP-4 Inhibitors in Short Bowel Syndrome
• Local Steroid Injection vs Placebo in Carpal Tunnel Syndrome
• Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea
• Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women
• A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -
• Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome
• Acupuncture or Metformin for Insulin Resistance in Women With PCOS
• A Comparison of Letrozole and Clomifene Citrate
• Dobutamaine Versus Milrinone in Cardiorenal Syndrome
• Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
• The Effect of Horizant (Gabapentin Enacarbil) on Augmentation
• Epicardial Ablation in Brugada Syndrome
• A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
• Colonoscopy-related Pain Predicts the Treatment Response of Amitriptyline in Patients With Irritable Bowel Syndrome
• The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
• EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
• Effect of Metformin on Insulin Sensitivity and Pan-Arterial Vascular Function in Adults With Metabolic Syndrome
• Non-surgical Periodontal Therapy and Myo-inositol in Polycystic Ovary Syndrome Women Having Chronic Periodontitis
• Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
• A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease
• Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
• Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome
• Patent Versus Generic Clopidogrel in Acute Coronary Syndrome
• Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT
• Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS
• Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS)
• A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
• The Influence of Timing of Cabergoline Initiation on Prevention of OHSS
• Effects of Dexmedetomidine Used in Continuous Thoracic Paravertebral Blocks
• Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes
• Comparing Ticagrelor Versus Clopidogrel on Microcirculation
• Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
• A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
• Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs
• An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)
• UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome
• A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
• Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome
• Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone
• Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)
• Pharmacokinetics of Apixaban in Nephrotic Syndrome
• Study to Evaluate Imetelstat (GRN163L) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
• Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)
• Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome
• Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
• Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
• Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
• An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
• Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
• Therapeutic Anticoagulation Strategy for Acute Chest Syndrome
• COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
• Sonography-guided Steroid Injection for Carpal Tunnel Syndrome
• Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS
• Pain Relief In Irritable Bowel Syndrome
• Low-dose IL-2 ( Interleukin-2) Treatment in Macrophage Activation Syndrome（MAS）
• Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome
• Impact of Intrathecal Morphine on Sleep Apnea Syndrome
• Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)
• Pharmacological Treatment of Rett Syndrome With Statins
• Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients
• Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
• Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes
• Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
• Cost-utility and Biological Underpinnings of MBSR in Fibromyalgia Syndrome
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
• Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)
• Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome
• Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )
• Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma
• Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome
• Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome
• Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
• Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies
• This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Acces
• Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
• Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome
• Refeeding Syndrome in Cancer Patients
• Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
• Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS
• Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
• Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
• Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
• Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
• Oral Nitrite Trial for Hypertension and Metabolic Syndrome
• Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide
• Sevoflurane and Hyperperfusion Syndrome
• A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes
• Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
• Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
• Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
• CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
• Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome
• A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
• Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
• Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
• Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
• Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome
• Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers
• Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome
• Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)
• JET-GBS - Japanese Eculizumab Trial for GBS
• Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
• A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C
• Efficacy and Safety of HE10 for Dry Eye Syndrome
• The RCT of Acupuncture on PCOS Combined With IR
• The Clinical Trial of Acupuncture Pre-treatment on PCOS
• The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure
• Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome
• Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting
• Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant
• The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
• IV Iron Treatment of Restless Legs Syndrome
• A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age
• CER-001 Atherosclerosis Regression ACS Trial
• Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS
• Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients
• Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
• Complement Inhibition in aHUS Dialysis Patients
• Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
• A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
• Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome
• Catatonia in Nodding Syndrome and Lorazepam Treatment
• Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes
• Phlebotomy and Polycystic Ovary Syndrome
• The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome
• Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
• IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS
• IL-2 for Multi Drug Resistant Nephrotic Syndrome
• YF476 and Type II Gastric Carcinoids
• Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome
• A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)
• Study of Clinical Efficacy and Safety of Tosedostat in MDS
• The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome
• Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)
• Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia
• Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS)
• Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )
• Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome
• Study of DSP-7888 in Patients With Myelodysplastic Syndrome
• Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS
• Study of Efficacy of CDZ173 in Patients With APDS/PASLI
• Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects
• Investigation of the Safety of Intranasal Glulisine in Down Syndrome
• A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7)
• Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients
• Botulinum Toxin A Injections in Patients With Fowler's Syndrome
• Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)
• Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome
• Safety Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)
• Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy
• Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome
• Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of Age
• Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the H
• Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection
• Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094
• Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
• Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome
• Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I
• Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study
• A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)
• Homeopathic Treatment of Premenstrual Syndrome
• A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome
• Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
• Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia
• Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS
• Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome
• Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome
• Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)
• Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery
• Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
• Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
• Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome
• Alpha Lipoic Acid on Clinical and Electrophysiological Recovery in Carpal Tunnel Syndrome Undergoing Surgical Release
• Acupuncture Versus Clonazepam in Burning Mouth Syndrome
• Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia
• European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
• Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease
• Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
• Effect of Gymnema Sylvestre on Metabolic Syndrome and Insulin
• A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients
• Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome
• Clinical Effectiveness of Enteric Coated(E.C.) Anise-oil on Irritable Bowel Syndrome
• A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome
• Reverse Transcriptase Inhibitors in AGS
• Caecal pH as a Biomarker for Irritable Bowel Syndrome
• rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome
• Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
• Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome
• Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II
• Adding Prednisolone During Ovulation Induction With CC in Lean Women With CC Resistant PCOS
• Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study
• Immunotherapy and Paraneoplastic Neurological Syndromes
• Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome
• Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
• Effects and Plasma Concentration of Ticagrelor, After Crushed and Non-crushed Intake, After Acute Coronary Syndrome
• Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)
• Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome
• Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome
• VALIDATION OF A PREDICTIVE MODEL OF RESPONSE TO ROMIPLOSTIM IN PATIENTS WITH IPSS LOW OR INTERMEDIATE-1 RISK MDS AND THROMBOCYTOPENIA
• Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
• Pinaverium and Herbs for Irritable Bowel Syndrome Treatment: an Onset and Offset Study (PHIBEST)
• A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
• Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
• The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
• Timing of Initiation of LMWH Administration in Pregnant Women With APS
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
• Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
• Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome
• Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome
• Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort Study
• Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
• Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
• Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation
• Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome
• A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome
• A Multicenter, Randomized, Open Label Trial of a New Animal Extracted Surfactant to Treat RDS in Preterm Infants
• Study of KRN23 in Adult Subjects With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
• Down Syndrome Memantine Follow-up Study
• Use of Warfarin After the First Trimester in Pregnant Women With APS
• Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome
• Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
• Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
• Rosuvastatin Effect on Telomere-telomerase System in ACS
• Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational Study
• Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome
• Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes
• Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
• Aerosolized Surfactant in Neonatal RDS
• A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
• Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome
• Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
• Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)
• Galantamine Effects in Patients With Metabolic Syndrome
• Stem Cell Transplantation for Stiff Person Syndrome (SPS)
• Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes
• Trial With Metformin in Women With Polycystic Ovary Syndrome
• Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)
• HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients
• Study of TCP-ATRA for Adult Patients With AML and MDS
• Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations
• ACE-536 Extension Study - Myelodysplastic Syndromes
• Response of VEGF and AT-II to HCG in PCOS
• Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes
• Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
• A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome
• Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome
• Vitamin D in the Treatment of Primary Restless Legs Syndrome
• Endobarrier Treatment in Women With PCOS
• Mesoglycan, Vascular Reactivity and Metabolic Syndrome
• The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
• Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™
• Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
• Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
• Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)
• Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)
• A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001
• Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women
• A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)
• A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals
• Close Kinetic Chain Exercise With Kinesio Taping in the Management of Patellofemoral Pain Syndrome
• Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes
• Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
• Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
• N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome
• Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
• Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)
• B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.
• Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes
• Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
• GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
• A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
• GWPCARE5 - An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
• Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
• Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS
• Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome
• Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
• Resveratrol in Metabolic Syndrome
• Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study
• A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
• Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
• Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
• The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
• Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
• Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell
• Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
• Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS
• Botox for Treatment of TMJ Disorder With Bruxism
• Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
• Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
• Metformin Treatment in Polycystic Ovary Syndrome (PCOS)
• Comparison of MEOPA + Paracetamol Versus Morphine Treatment in Acute Coronary Syndrome Analgesia.
• Citocoline for Treatment of FXTAS
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
• Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial
• Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS
• Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome
• REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.
• Expanded Access Study Amifampridine Phosphate in Congenital Myasthenic Syndrome (CMS)
• Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
• Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome
• Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
• Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
• Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
• A Study of Xiang-Sha-Liu-Jun-Zi-Tang in Patients With Irritable Bowel Syndrome
• Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
• Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation
• Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
• Darbepoetin Alfa MDS Companion Protocol
• Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome
• Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
• Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
• MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
• Trial of an Alternate Mode of Providing Artificial Breaths to Children With Very Severe Pneumonia
• Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study)
• Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
• Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome
• Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)
• Effects of Botox in Obstructed Defecation Syndrome
• A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
• A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
• Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
• Rivaroxaban in Thrombotic Antiphospholipid Syndrome
• Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
• Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)
• Enoxamed Study in the Treatment of Acute Coronary Syndromes
• PD of VAY736 in Patients With Primary Sjögren's Syndrome
• Iliac Vein Stenting in Advanced Chronic Venous Insufficiency
• Establishment of Ideal IV Sedative Regimen for Successful Fiberoptic Bronchoscopy in Assessing the Site, Severity of Sleep Apnea Syndrome
• Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL
• Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)
• Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
• A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)
• Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome
• Butrans for Treatment of Restless Legs Syndrome
• Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery
• The Use of Heliox in Obstructive Sleep Apnea Syndrome
• Intensive Arterial Pressure Control in Acute Coronary Syndrome
• FAAH Inhibitor Trial for Adults With Tourette Syndrome
• Safety Study of TPI-287 to Treat CBS and PSP
• Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome
• Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes
• Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
• Horner's SD After Thoracic Epidural Block
• Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
• Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies
• A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
• Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
• Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
• Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline
• The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
• Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
• Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
• Using Saline for Myofascial Pain Syndromes (USAMPS)
• 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent
• An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome
• SCT Plus Immune Therapy in Average Risk AML/MDS
• Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome
• Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
• Rivaroxaban for Antiphospholipid Antibody Syndrome
• Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
• Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
• Clinical Trial Using Humira in Netherton Syndrome
• Safety and Efficacy Study of Acthar in Subjects With ARDS
• Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
• Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
• Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids
• Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome
• Cytokine Inhibition in Chronic Fatigue Syndrome Patients
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS
• Phase 2 Study of EPI-743 in Children With Pearson Syndrome
• Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)
• Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
• Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
• Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome
• Short Bowel Syndrome and Teduglutide Versus Placebo
• Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
• Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity
• Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management
• Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
• A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.
• Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery
• Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)
• Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
• Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)
• A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
• Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome
• Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
• Hyperbaric Oxygen Treatment to Treat Mild Traumatic Brain Injury (mTBI)/Persistent Post-Concussion Syndrome (PPCS)
• Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)
• Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes
• Long Acting GnRH Antagonist in PCOS Women Undergoing IVF
• Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
• Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant
• Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation
• Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome
• Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome
• Safety and Efficacy of PG101 for Dry Eye Syndrome
• LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients
• Three Dosing Schedules of Oral Rigosertib in MDS Patients
• A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome
• LIPT - Liraglutide in Polycystic Ovary Syndrome
• Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS
• BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
• Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome
• Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
• A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B
• Telotristat Etiprate for Carcinoid Syndrome Therapy
• CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
• Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome
• Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)
• Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
• Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome
• Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome
• SWS And Daytime Functioning in Chronic FatiguE Syndrome (SAFFE)
• Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?
• Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
• Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
• Preventing Alcohol Withdrawal Syndrome With Oral Baclofen
• Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy
• An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)
• Adoptive Transfer of Haplo-identical DLI for AML and MDS
• Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
• A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk
• Paradigm Shift in the Treatment of Patients With ACS
• Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome
• Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)
• Injection Versus Splinting in Carpal Tunnel Syndrome
• Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
• An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
• Carpal Tunnel Syndrome - Randomized Clinical Trial Evaluating Effectiveness of Ultrasound in Corticosteroid Injection
• Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
• Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .
• Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel
• Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater Trochanteric Pain Syndrome
• TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial
• Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia
• Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
• Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
• Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms
• Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome
• Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
• A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)
• Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
• An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome
• Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome
• Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome
• Sorafenib for Hepatopulmonary Syndrome
• Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)
• Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
• CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS
• Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)
• Post Study Continuation of C7 for G1D
• Metformin in the Diastolic Dysfunction of Metabolic Syndrome
• Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.
• Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
• Safety and Pharmacokinetics Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
• Oxytocin Trial in Prader-Willi Syndrome
• Curosurf/Budesonide for Infants With Respiratory Distress Syndrome
• A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome
• 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
• Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)
• A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
• A Study of Galunisertib in Participants With Myelodysplastic Syndromes
• Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
• Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
• Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
• Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
• The Cancer of the Pancreas Screening-5 CAPS5)Study
• PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
• Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
• Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
• Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
• Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA
• Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
• Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes
• Modafinil and Cognitive Function in POTS
• Hyperbaric Oxygen for Civilian Post-concussive Syndrome
• Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
• Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
• Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment
• A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome
• Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
• Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)
• Switching From Oral Dopamine Agonists to Rotigotine
• The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
• Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary
• Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
• The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome
• BMN 110 Phase 3B in Australian Patients
• Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
• The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS
• Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant
• Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
• Improving Outcomes in Neonatal Abstinence Syndrome
• Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML
• Clomiphene Stair-Step Protocol for Ovulation Induction in Women With Polycystic Ovarian Syndrome
• A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
• Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients
• Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
• A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
• Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
• The Oxford Marfan Trial
• Subsensory Sacral Nerve Stimulation for Irritable Bowel Syndrome
• Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
• Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
• Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo
• A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
• Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis
• Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
• A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome
• Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
• Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
• Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine
• Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
• Effects of Bolus Surfactant Therapy on Peripheral Perfusion Index and Tissue Carbon Monoxide
• SOMATULINE Autogel 90 mg IN DUMPING SYNDROME
• The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
• Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
• Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study
• Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
• Study of Acamprosate in Fragile x Syndrome
• Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in Polycystic Ovary Syndrome
• Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
• Colchicine for Acute Coronary Syndromes
• A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome
• Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs
• Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
• Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille Syndrome
• CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy
• Renal Denervation in Patients After Acute Coronary Syndrome
• A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
• Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome
• Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome
• A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
• Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
• Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
• Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
• Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Incretin Effect in PCOS Women
• A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
• Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
• Aldosterone Antagonism and Microvascular Function
• Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome
• Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
• Comparison of NSAID Patch Given in Monotherapy and NSAID Patch in Combination With Transcutaneous Electric Nerve Stimulation, Heating Pad, or Topical Capsaicin in the Treatment of Patients With Myofascial Pain Syndrome of the Upper Trapezius: A Pilo
• Efficacy and Safety of AQX-1125 in IC/BPS
• A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myelodysplastic Syndrome
• A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study
• Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
• Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
• Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
• A Study of AZD4901 in Females With Polycystic Ovary Syndrome
• Brilinta DaYu Study
• A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
• Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)
• Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer
• Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
• Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.
• Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
• A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS
• Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
• Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coro
• Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops
• Study of the Effect of GS-6615 in Subjects With LQT-3
• The Organ Protection of Astragalus in Subjects With Metabolic Syndrome
• Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
• A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
• Treatment for Endogenous Cushing's Syndrome
• Probiotics in the Treatment of Irritable Bowel Syndrome
• Probiotics in the Treatment of Irritable Bowel Syndrome
• Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).
• Compassionate Use of Stiripentol in Dravet Syndrome
• DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
• Treatment Trial of Subclinical Hypothyroidism in Down Syndrome
• Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
• Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy
• Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome
• Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome
• Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies
• Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)
• Phase 2 Study of EPI-743 for Treatment of Rett Syndrome
• Immune Disorder HSCT Protocol
• An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome
• Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
• Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome
• A Clinical Study to Assess the Efficacy and Safety of DA-3002
• Efficacy and Safety Study of Ticagrelor
• Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
• Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
• Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
• Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation
• Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas
• Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
• Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
• Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal
• Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma
• Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome
• Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor
• Intrathecal Magnesium for Same-day-surgery
• Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)
• A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
• Myo-inositol Versus Metformin in Obese Women With Polycystic Ovary Syndrome
• Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome
• The Use of Zoledronic Acid to Complex Regional Pain Syndrome
• Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome
• Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin
• Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
• Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome
• Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome
• Nicotine Treatment of Cognitive Decline in Down Syndrome
• Treatment of Rett Syndrome With Recombinant Human IGF-1
• The Elderly ACS II Trial
• Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & Adipose
• Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
• Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
• Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
• Effect of Rowachol on Prevention of Postcholecystectomy Syndrome
• Treatment Use of 3,4-Diaminopyridine
• Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
• GRASSP: Gralise® for Spine Surgery Pain
• Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)
• A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome
• The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome
• Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
• Rebamipide AND Sjögren Syndrome
• Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns
• The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
• The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study
• Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
• The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome
• Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation
• the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome
• An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome
• A Study of RO4917523 in Pediatric Patients With Fragile X Syndrome
• Oral and IV Baclofen in Adult Volunteers
• Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure
• A Multi-Center Study Subjects With Dry Eye Syndrome
• Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients
• Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma
• Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
• APG101 in Myelodysplastic Syndrome
• A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
• NAS Treatment - Opiate Versus Non-Opiate
• Growth Response in Girls With Turner Syndrome
• Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
• Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome
• Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
• Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012
• Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
• Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
• Ganaxolone Treatment in Children With Fragile X Syndrome
• Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
• Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies
• Treatment of Neonatal Abstinence Syndrome
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
• Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome
• Open-Trial of EPI-743 for Adults With Tourette Syndrome
• Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)
• Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.
• Rituximab Trial for Pediatric Nephrotic Syndrome
• Comparison of Aliskiren vs Negative Controls on Aortic Stiffness in Patients With MFS
• A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
• Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?
• Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome
• Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
• Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
• A Safety Study of NNZ-2566 in Patients With Rett Syndrome
• TRARO (Traumeel® S in Rotator Cuff Syndrome)-Study
• The Effectiveness of Non-surgical Integrative Package on Failed Back Surgery Syndrome
• Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE)
• Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
• Exercise, Statins, and the Metabolic Syndrome
• Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
• Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation
• Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
• Tocilizumab for the Treatment of Behcet's Syndrome
• A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome
• Low Dose Cyclosporin A in Primary Sjögren Syndrome
• A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
• Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
• Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome
• Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
• VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel
• Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate
• Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
• Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian Syndrome
• TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)
• Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome
• Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome
• Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines
• Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome
• Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study
• Citalopram for Sx/Util in Acute Coronary Syndrome Patients
• A Molecular and Functional Brain Imaging Study in Individuals With Down Syndrome and Healthy Controls Following Single Dose RG1662
• Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
• Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
• Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome
• Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
• Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
• 5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome
• Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome
• Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
• Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
• First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
• To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome
• Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
• Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
• PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants
• Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
• A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome
• POEMS Syndrome Treatment With Lenalidomide
• Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
• The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome
• Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome
• Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
• Preoperative Gabapentine for Carpal Tunnel
• Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
• Levothyroxine for Children With Euthyroid Sick Syndrome
• Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome
• Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
• Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome
• Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
• Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome
• Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
• Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)
• Cortisol and Nutritional Sympathetic Responsiveness
• Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
• NK Cells in Cord Blood Transplantation
• Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial
• Pasireotide Therapy in Patients With Nelson's Syndrome
• The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
• A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients
• A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
• Ghrelin Suppression by Octreotide in Prader-Willi
• The Effect of Triflusal on Peripheral Microcirculation Dysfunction
• Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome
• Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome
• Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS
• Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome
• Verapamil as Therapy for Children and Young Adults With Dravet Syndrome
• Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
• Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
• L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome
• Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients
• Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome
• Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome
• Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome
• Metformin in Pregnancy in Women With Polycystic Ovary Syndrome
• Multicenter Vitamin E Trial in Aging Persons With Down Syndrome
• Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
• The Value of Botox-A for Management of Low Anterior Resection Syndrome
• Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.
• Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary Syndrome
• Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome
• Sodium Oxybate in Patients With Chronic Fatigue Syndrome.
• Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome
• Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome
• The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)
• Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children
• Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
• Phase II 5-Azacytidine Plus VPA Plus ATRA
• Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical Trial
• Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)
• Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
• Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy
• A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azacitidine in Japanese Patients With Myelodysplastic Syndromes
• Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)
• The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Participants With Interstitial Cystitis /Bladder Pain Syndrome (MK-7264-005)
• Ovarian Hyperstimulation Syndrome and Cabergoline
• Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPS
• Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome
• Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
• A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
• A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
• The Effect of Neu-P11 on Symptoms in Patients With D-IBS
• The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
• Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas
• An Open Label Extension Study in Subjects With Fragile X Syndrome
• Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
• COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)
• Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder
• A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
• Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
• TevaGastrim for Stem Cell Mobilization Sibling Donors
• Effect of Pentoxifylline on Tight Junctions (TJs) of Intestinal Mucosa in Patients With Irritable Bowel Syndrome(IBS)
• Liraglutide Use in Prader-Willi Syndrome
• Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
• VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
• Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome
• A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
• Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers
• Stiripentol in Dravet Syndrome
• Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
• Minocycline in the Treatment of Angelman Syndrome
• Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response
• Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
• Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome
• Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Controlled Level EVERolimus in Acute Coronary Syndromes
• Spironolactone Plus Metformin in Polycystic Ovary Syndrome
• Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
• Steroid Treatment for Hypereosinophilic Syndrome
• Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
• Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
• Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome
• Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome
• Placebo Controlled Trial of Dextromethorphan in Rett Syndrome
• Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.
• Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine
• Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome
• Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis
• Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome
• Use of Somatropin in Turner Syndrome
• A Study of RO4917523 in Patients With Fragile X Syndrome
• Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)
• A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome
• A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome
• Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
• Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance
• HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
• Comparative Efficacy and Safety of Fenoverine
• Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment
• Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea
• Polycystic Ovary Syndrome - Improving Outcomes
• Effects of N-acetylcysteine on Low T3 Syndrome
• Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome
• Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
• A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes
• Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
• A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
• Administration of Donor T Cells With the Caspase-9 Suicide Gene
• Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity
• Index of Microcirculatory Resistance After Drug-Eluting Stent Implantation With High Dose Atorvastatin Loading
• Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)
• A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
• Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
• Proteomics & Glyco-Proteomic Analysis of Follicular Fluid
• Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
• Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)
• Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)
• Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)
• Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome
• The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)
• Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome
• Trial of Sertraline to Treat Children With Fragile X Syndrome
• Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)
• Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
• Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)
• Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
• Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza)
• Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome
• Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
• Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome
• Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome
• Tanshinone in Polycystic Ovary Syndrome
• Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
• Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement Syndrome
• Statins Evaluation in Coronary Procedures and Revascularization Trial
• Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
• Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS
• Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
• Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome
• A Study of RG1662 in Individuals With Down Syndrome
• Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
• Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome
• SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
• Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
• Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)
• The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome
• Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)
• A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome
• Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
• A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
• Calcium for Prevention of Ovarian Hyperstimulation Syndrome
• Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome
• Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
• History of the KSHV Inflammatory Cytokine Syndrome (KICS)
• Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome
• The Effect of Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome
• Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
• Glutamine for the Treatment of Patients With Irritable Bowel Syndrome
• The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
• Botulinum Toxin Injections for Thoracic Outlet Syndrome
• Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs
• Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)
• GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer
• Brain Imaging and Treatment Studies of the Night Eating Syndrome
• An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome
• Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
• Flaxseed Lignan (Brevail)
• Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level
• Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients
• Egcg, a dyrk1a Inhibitor as Therapeutic Tool for Reversing Cognitive Deficits in Down Syndrome Individuals.
• Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome
• Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
• Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome
• A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
• Ilaris® Effects in Schnitzler Syndrome (ILESCH)
• Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant
• Polycystic Ovary Syndrome Genetics and Treatment Response
• Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome
• A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
• Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
• Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome
• An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes
• Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
• A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
• A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1
• Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
• Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
• Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
• An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
• Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)
• Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
• Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome
• GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms
• Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia
• Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism
• Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention
• Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg
• Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
• Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy
• Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
• Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome
• MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry
• Metformin in Postmenopausal Women With Metabolic Syndrome
• A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
• Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
• Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
• Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia
• Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
• Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder
• Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)
• Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients
• Simulated Driving Study in Restless Legs Syndrome
• Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome
• Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome
• REQUIP RLS Post Marketing Surveillance
• Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)
• Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study
• Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
• A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
• Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome
• Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
• Sleep Apnea Syndrome and Vitamin D
• Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
• Effect of Eplerenone on Endothelial Function in Metabolic Syndrome
• The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment
• Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
• Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
• Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine
• Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)
• Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
• Comparison Of Surfactant Lung Lavage With Standard Care In The Treatment Of Meconium Aspiration Syndrome
• The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)
• Dose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome
• Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI
• Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
• Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
• Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
• Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes
• Ranolazine, Ethnicity and the Metabolic Syndrome
• Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)
• Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
• GLP Analogs for Diabetes in Wolfram Syndrome Patients
• Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes
• Acamprosate in Youth With Fragile X Syndrome
• Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients
• Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS
• Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
• Comparison of Medical Therapies in Marfan Syndrome.
• Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome
• Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
• Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome
• Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia
• Empirical Versus Preemptive Antifungal Therapy
• Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
• Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
• Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
• A Trial of Levodopa in Angelman Syndrome
• Efficacy and Safety of Canakinumab in Schnitzler Syndrome
• A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients
• Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
• GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome
• The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry Eye
• Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome
• Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood
• TKI 258 in Von Hippel-Lindau Syndrome (VHL)
• Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients
• Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome
• Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea)
• Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
• Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers
• Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome
• Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome
• Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)
• Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)
• Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
• This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
• Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.
• Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents
• Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
• Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
• Ilaris (Canakinumab) in the Schnitzler Syndrome
• Ecopipam Treatment of Tourette Syndrome
• Assessment of Desogestrel in Ondine Syndrome
• Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome
• Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).
• A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
• Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions
• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
• Effect of Vitamin D on Metabolic Parameters in Patients With the Metabolic Syndrome
• A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Synd
• Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles
• A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients
• Efficiency Study of Siwu Tang to Treat Brain Hypoperfusion Syndrome
• Thymus Transplantation Safety-Efficacy
• A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
• A Study of KCT-0809 in Patients With Dry Eye Syndromes
• Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)
• Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
• Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
• Local Vasoconstriction in Postural Tachycardia Syndrome
• Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
• Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
• Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
• Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
• Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
• Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
• OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
• Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome
• Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes
• Simvastatin Effect on the Incidence of Acute Lung Injury/Adult Respiratory Distress Syndrome (ALI/ARDS)
• An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
• An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
• Safety and Efficacy of Rasagiline in Restless Legs Syndrome
• Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
• Inflammatory Mediators in Obstructive Sleep Apnoea Syndrome; Mechanisms of Production and the Effect of Long Term Antioxidants Administration
• Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease
• An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)
• Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine
• Statin Contrast Induced Nephropathy Prevention
• Effect of Magnesium Administration in Subjects With Family History of Diabetes or Metabolic Syndrome
• Revlimid in Transfusion Dependent Patients
• Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome
• Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
• High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma
• Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
• Clonidine for Neonatal Abstinence Syndrome Study
• Administration of IV Laronidase Post Bone Marrow Transplant in Hurler
• Study of Panitumumab in the Treatment of Carcinoid Syndrome
• N-acetylcysteine (NAC) for Children With Tourette Syndrome
• Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome
• Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome
• Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome
• Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
• Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
• INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
• Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
• Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation
• Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children
• Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome
• Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
• Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
• Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
• RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
• Hyperuricemia on Hypertension and Metabolic Syndrome
• Botulinum A Toxin in the Treatment of Patients With Painful Bladder Syndrome
• Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome
• B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
• B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
• Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes
• Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients
• Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
• Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
• Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS)
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
• A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304)
• Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics
• Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome
• Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
• Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists
• Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne Syndrome
• Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS
• Effect of Berberine on Hormonal and Metabolic Features in Obese Women With Polycystic Ovary Syndrome (PCOS)
• Dexamethasone Efficacy in HELLP I Syndrome
• Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure
• A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
• Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
• Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
• Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea
• VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
• Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
• AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
• Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
• Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome
• Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients
• Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection
• Testosterone Replacement in Metabolic Syndrome and Inflammation
• The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome
• Randomized Controlled Study of Donepezil in Fragile X Syndrome
• Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
• Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
• Polycystic Ovary Syndrome (PCOS): Effect Of Letrozole and Berberine
• Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients
• Metformin and Folate in Pregnant Polycystic Ovary Syndrome(PCOS) Women
• Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
• Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome
• Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
• Temsirolimus in Myelodysplastic Syndrome (MDS)
• Novel Treatment for Syndromic Ichthyoses
• Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)
• Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
• Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes
• The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada
• Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome
• Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm
• Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
• Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression
• Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome
• The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)
• Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in Children
• Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children
• Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome
• European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
• Erlotinib in Higher Risk Myelodysplastic Syndrome
• A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
• Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
• Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
• Rivastigmine Study in Adolescents With Down Syndrome
• Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
• Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q
• Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic Syndrome
• A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)
• Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
• The Effect of Atorvastatin on Androgens, Glucose Metabolism and Inflammation in Polycystic Ovary Syndrome (PCOS) Women
• Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
• Endometrial Effects of Metformin Action in Women With Polycystic Ovarian Syndrome (PCOS)
• Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
• Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
• Topical Cyclosporine Suspension for the Treatment of Brittle Nails
• Clofarabine in High Risk Myelodysplastic Syndrome (MDS)
• Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)
• Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
• 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects
• Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies
• Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients
• Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome
• Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic Syndrome
• Trial of Minocycline to Treat Children With Fragile X Syndrome
• Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
• Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
• Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome
• Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
• Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
• Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
• A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome
• 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
• Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients
• The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial
• Prospective, Multicenter, Open Label and Single-arm Study of Darbepoetin Alfa for Anemia in Myelodisplastic Syndrome Patients.
• Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)
• Melatonin and the Metabolic Syndrome
• Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo
• Lenalidomide as Maintenance Therapy After Combination Chemotherapy With or Without Rituximab and Stem Cell Transplant in Treating Patients With Persistent or Recurrent Non-Hodgkin Lymphoma That Is Resistant to Chemotherapy
• Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome
• LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)
• Comparison of Depression Interventions After Acute Coronary Syndrome
• Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome
• Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation
• An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
• Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
• Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes
• Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia
• Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome
• Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome
• Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission
• A Study With RO4917523 in Patients With Fragile X Syndrome
• Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)
• Acupuncture in Patients With Carpal Tunnel Syndrome ~ A Randomized Controlled Trial
• Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome
• An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome
• To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
• Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
• Azithromycin in Bronchiolitis Obliterans Syndrome
• Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome
• Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome
• A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome
• N-acetyl Cysteine and Clomiphene Citrate or Metformin and Clomiphene Citrate for Women With CC Resistant Polycystic Ovary Syndrome (PCOS).
• Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I
• Short-term Structured Exercise Training Program Plus Diet Intervention in Patients With Polycystic Ovary Syndrome (PCOS)
• Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients
• Effect of Nafamostat on Postreperfusion Syndrome (PRS)
• The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
• Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
• Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome
• Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
• Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemo
• Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
• The Effects of Metformin on Pregnancy and Miscarriage Rates in Polycystic Ovary Syndrome (PCOS)
• Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes
• Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
• Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance
• Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
• Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome
• Pilot Study of the Effects of the Desipramine on the Neurovegetative Parameters of the Child With Rett Syndrome
• Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
• Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
• Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
• Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.
• Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary Syndrome
• Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
• Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
• PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinas
• Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction
• Erlotinib Study for Myelodysplastic Syndrome (MDS)
• A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome
• Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
• Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome
• Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
• Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes
• The Treatment of Lenalidomide in Patients With POEMS Syndrome
• Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)
• Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
• Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome
• Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)
• Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
• Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
• The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
• A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients
• An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder
• O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
• A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
• NOV-002 in Myelodysplastic Syndrome (MDS)
• Observational Prospective Study on Patients Treated With Norditropin®
• Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
• To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)
• Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)
• Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome.
• Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
• Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome
• Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
• Evaluation of Serum Prostatic Specific Antigen (PSA) After Cyproterone Compound Treatment Compared With Oral Contraceptives Pill in Hirsute Polycystic Ovary Syndrome Patients
• Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) Patients
• Compare the Efficacy of Acupuncture Therapy and Carbamazepine Oral Dosage in Patients With Carpal Tunnel Syndrome by Multiple Excitability Test
• Restless Legs Syndrome Treatment With Botulinum Toxin
• Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer
• Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome（Diarrhea Type）
• Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
• PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives
• A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
• Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
• Escalation Study to Determine Bioavailability of a Single Oral Dose of Decitabine in Patients With Myelodysplastic Syndrome (MDS)
• Efficacy and Safety Assessment of an Anti-Cold Preparation in the Symptomatic Treatment of Common Cold and Flu-Like Syndrome
• Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
• Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
• Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
• Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)
• The Use of VSL#3 in Irritable Bowel Syndrome in Children
• A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
• Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
• Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary Syndrome
• Efficacy of Abciximab Bolus Only Regimen in Providing Inhibition of Platelet Action Over Time
• Topical Rapamycin for Fibrofolliculomas
• Continuous Positive Airway Pressure and Acetazolamide to Treat Sleep Apnea Syndrome Patients at Altitude
• Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
• Hydroquinidine Versus Placebo in Patients With Brugada Syndrome
• The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome
• Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes
• Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice
• A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®
• Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS)
• Study of Indoleamine 2,3-dioxygenase Activity, Serum Levels of Cytokines, BDNF, BH4 and Mirtazapine Efficacy in Fibromyalgia Syndrome
• Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
• A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
• Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome
• A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome
• Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin
• Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities
• Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
• Administration of Kisspeptin to Subjects With Reproductive Disorders
• Vascular Effects of Hesperidin in Metabolic Syndrome
• Cheno Effect on Transit in Health and IBS-C
• Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children
• Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)?
• Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary Syndrome
• MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
• A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes
• BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)
• Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
• Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)
• Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
• A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
• Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
• Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
• Studying Fentanyl in Patients With Cancer
• 5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)
• Riluzole in Fragile X Syndrome
• Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments
• Letrozole Combined With Gonadotropins (Gn) for Ovarian Stimulation Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) in Patients With Polycystic Ovary Syndrome (PCOS)
• Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome
• Liq-NOL Efficacy in Pediatric Patients With Down Syndrome
• Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)
• Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome
• Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
• Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)
• A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
• Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome
• Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome
• Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
• Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine
• Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
• A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
• Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome
• Efficacy of Minoxidil in Children With Williams-Beuren Syndrome
• Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
• The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality
• Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)
• 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
• Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
• Initiating Transdermal Estradiol Therapy in Turner's Syndrome
• Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany
• Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
• The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors
• Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia
• Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
• Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel
• Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia
• Add-on Pilot Trial of Minocycline to Treat Fragile X Syndrome
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
• Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome
• Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
• Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome
• Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
• Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
• Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy
• A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
• A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients
• A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I
• Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen
• Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia
• Drug Intervention in Chronic Fatigue Syndrome
• Probiotics in Irritable Bowel Syndrome
• Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
• Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
• Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
• Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
• Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women
• Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
• Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS
• Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome
• Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)
• Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism
• Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
• Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome
• Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
• Phase III Acute Coronary Syndrome
• A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome
• A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome
• Acarbose Cardiovascular Evaluation Trial
• Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
• Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
• Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer
• Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy
• Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
• Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
• A Translational Approach to Gitelman Syndrome
• Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
• Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
• The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study
• Effect of Fenofibrate on Sleep Apnea Syndrome
• Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer
• Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome
• Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome
• Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome
• Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome
• Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.
• Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
• Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)
• An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
• RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes
• Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants
• Steroid Injection Treatment of Carpal Tunnel Syndrome
• Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer
• Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
• Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
• Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
• The International Collaborative Exfoliation Syndrome Treatment Study
• Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
• Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
• Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment
• Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
• Propofol Versus Midazolam as Premedication for Preterm Neonates With Respiratory Distress Syndrome (RDS)
• A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
• Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant
• A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome
• PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene
• Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
• Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation
• Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
• Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial
• Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS)
• Bendamustine in Acute Leukemia and MDS
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
• Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II
• Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
• Empiric Quinidine for Asymptomatic Brugada Syndrome
• Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
• Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome
• Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
• Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I
• Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer
• Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers
• Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
• Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
• Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
• An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
• Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT
• Interleukin-2 Treatment for Wiskott-Aldrich Syndrome
• Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen
• High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML
• A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome
• Effect of Treatment With Stress-Doses Glucocorticoid in Patients With Acute Respiratory Distress Syndrome (ARDS)
• Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
• FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
• The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
• A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy
• Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
• Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome
• Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome
• Inflammation and Vascular Function in Atherosclerosis
• Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
• Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)
• Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)
• Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
• The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
• Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
• FMS European Long-Term Study
• Compromised Microcirculation in Women With Polycystic Ovary Syndrome
• Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
• Targeting Inflammation in Acute Coronary Syndrome Using Colchicine
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
• A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)
• Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents
• Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study)
• Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance
• Efficacy of Rivastigmine in Patients With Down Syndrome
• Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)
• An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)
• Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS
• FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes
• Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)
• Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome
• Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
• Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
• Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
• Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
• An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis
• Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
• Effect of Bifidobacterium on Irritable Bowel Syndrome
• Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome
• Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
• Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid
• The Effect of Serotonergic Modulation on Intestinal Permeability and Visceral Hypersensitivity in Healthy Individuals and Irritable Bowel Syndrome (IBS) Patients
• An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
• Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome
• Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
• A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
• China Intensive Lipid Lowering With Statins in Acute Coronary Syndrome
• Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
• Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects
• Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor
• Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
• Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
• Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
• Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome
• 5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
• Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
• Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
• Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease
• American Ginseng in Treating Patients With Fatigue Caused by Cancer
• Pregnancy in Polycystic Ovary Syndrome II
• Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients
• Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
• Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain
• Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome
• Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
• Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude
• Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)
• Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome
• Biseko Versus Albumin in Systemic Inflammatory Response Syndrome (SIRS) Patients
• Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study
• Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome
• Treatment of Lambert-Eaton Syndrome With 3,4 DAP
• Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women
• Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)
• A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.
• MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)
• Telmisartan Versus Ramipril After Acute Coronary Syndrome
• An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
• Botulinum Toxin for Carpal Tunnel Syndrome
• DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome
• Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
• Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)
• A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
• A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients
• Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal Men
• Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
• A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion
• Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)
• Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients
• Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS)
• LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
• Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
• Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial
• Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)
• Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
• Peripheral Dopamine in Postural Tachycardia Syndrome
• Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
• Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)
• Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
• Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease
• Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)
• Calfactant for Direct Acute Respiratory Distress Syndrome
• Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette Syndrome
• Gulf War Digestive Health Study
• Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome
• Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes
• The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome
• Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection
• A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome
• Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients
• A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
• Effects of Melatonin and Oxygen Consumption and Choroidal Blood Flow
• Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial
• Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients
• Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome
• Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
• Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload
• a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)
• Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
• Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
• Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome
• Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML
• Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
• Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
• A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
• Minocycline in Clinically Isolated Syndromes (CIS)
• Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
• Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
• Implications for Treatment of the Metabolic Syndrome
• Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
• Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome
• The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome
• Lansoprazole Versus Mosapride for Functional Dyspepsia
• Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome
• Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
• Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
• Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
• A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
• Neuroma Injections to Treat Restless Legs Syndrome - RCT
• Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
• Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)
• COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
• Fasturtec TLS Treatment / Prophylysis
• A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome
• Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)
• Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes
• Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome
• Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
• The Effect of Allopurinol on Insulin Resistance and Blood Pressure
• Intrathecal Enzyme Replacement for Hurler Syndrome
• Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome
• Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
• Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome
• Escitalopram Treatment of Night Eating Syndrome
• Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
• A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome
• Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MD
• Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial
• Rasburicase in Patients at Risk for Tumor Lysis Syndrome
• Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer
• A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS
• The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome
• Mesalazine Therapy in Patients With Irritable Bowel Syndrome
• A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS
• Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
• Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts
• Ribavirin for Hemorrhagic Fever With Renal Syndrome
• A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland
• Bupropion and Restless Legs Syndrome
• Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome
• Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)
• Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
• A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome
• A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
• The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome
• Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)
• Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
• Study of 99mTc-glucarate to Detect Acute Coronary Syndrome in Chest Pain Patients.
• Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
• Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
• Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
• Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
• Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
• Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
• Early Insulin and Development of ARDS
• Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
• Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome
• Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
• A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
• Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
• LBH589 in Refractory Myelodysplastic Syndromes (MDS)
• Trial of Dextromethorphan in Rett Syndrome
• Losartan Versus Atenolol for the Treatment of Marfan Syndrome
• Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome
• Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
• Saccharomyces Boulardii in Irritable Bowel Syndrome
• Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplas
• Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
• A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome
• Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
• Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
• Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome
• Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
• Autonomic Nervous System and Chronic Fatigue Syndrome
• Mechanisms Underlying Metabolic Syndrome in Obesity
• Phase I/II Thymus Transplantation With Immunosuppression #950
• A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
• Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness
• Long-Term Treatment With rhIGF-1 in GHIS
• The Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic Syndrome
• Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
• A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
• Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
• A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts
• Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
• Second-Line Treatments for Anovulatory Infertility in PCOS Patients
• Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
• Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event
• Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
• A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
• Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary Syndrome
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
• Study of Four Different Chemotherapy Regimens With or Without Total-Body Irradiation Followed by Umbilical Cord Blood Transplant in Treating Patients With Relapsed or Refractory Hematologic Cancer
• Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
• Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
• MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)
• Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome
• Treatment of the Dumping Syndrome With Lanreotide Autogel®
• Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue
• Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome
• Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome
• Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
• Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
• A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
• Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
• Safety of ON 01910.Na in Patients With Myelodysplasia
• A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)
• Rituximab in Patients With Relapsed or Refractory TTP-HUS
• Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome
• ASP8825 - Study in Patients With Restless Legs Syndrome
• Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
• A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol
• Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
• Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
• Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
• Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
• Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease
• Buprenorphine for the Treatment of Neonatal Abstinence Syndrome
• Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS
• The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome
• Low Dose Growth Hormone in Obese PCOS Women
• Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
• Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
• Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome
• Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
• APEX Study: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients With Cardiac Syndrome X
• A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
• A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679
• Sorafenib in Myelodysplastic Syndrome
• Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome
• A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
• Safety and Pharmacokinetic Study of BIO 300 Capsules
• Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
• A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)
• Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
• Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study
• Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
• Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
• Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome
• Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)
• Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
• SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
• Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
• Treosulfan-based Conditioning for Transplantation in AML/MDS
• Effect of a Fibrate and a Statin on Endothelial Dysfunction
• ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome
• Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
• Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
• Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers
• Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
• Effect of Testosterone Replacement on Insulin Resistance
• SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia
• A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome
• Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)
• Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
• Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis
• Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload
• Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
• Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes
• Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)
• Botulinum Toxin to Treat Restless Legs Syndrome
• Letrozole Versus Clomifene Citrate for Ovulation Induction
• Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
• Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
• Citalopram in Irritable Bowel Syndrome
• Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
• Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
• Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
• Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)
• Treatment of Anovulatory Infertility in PCOS Patients
• Safety, Tolerability, and Efficacy of Deferasirox in MDS
• IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
• Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
• A Clinical Study of Intravenous Immunoglobulin
• Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
• Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS
• Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
• Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin
• MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
• Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome
• Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
• The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
• Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome
• Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
• MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
• Sb-705498 Rectal Pain Study
• Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOS
• Diarrhea Predominant Irritable Bowel Syndrome in Females
• Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia
• Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
• A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes
• Systemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in Children
• Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200
• Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients
• Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
• Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
• Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome
• Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
• Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia
• Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome
• Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load
• Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome
• Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes
• Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
• Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
• Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
• Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
• A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
• Study of Pyridoxine for Hand-Foot Syndrome
• Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
• Growth Hormone Use in Adults With Prader-Willi Syndrome
• Treatment of Thoracic Outlet Syndrome (TOS) With Botox
• Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
• Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)
• D3-GHR Polymorphism and Turner Syndrome
• Metabolic Syndrome in PCOS: Precursors and Interventions
• Comparison of Autologous Serum and Umbilical Cord Serum Eyedrops for Dry Eye Syndrome
• The Efficacy and Safety of ITF2357 in AIS
• Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain
• Methylphenidate for Treating Children With ADHD and Tourette Syndrome
• PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
• Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome
• Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
• Metformin Suspension and Insulin Sensitivity
• A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome
• IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome
• Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy
• Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
• Insulin Sensitivity in Men With the Metabolic Syndrome
• Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study
• Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome--Pediatric Heart Network
• Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS
• Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
• Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
• Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
• Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
• Rituxan in Churg Strauss Syndrome With Renal Involvement
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
• Lenalidomide in Subjects With intermediate2 or High MDS Associated With a Deletion (DEL) 5q [31]
• Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
• Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
• Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
• 2 Arm Study of Clofarabine IV in MDS Patients
• Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
• Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)
• Growth Hormone Treatment of Women With Turner Syndrome
• A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
• Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food
• A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid
• Manipulation of Visceral Sensitivity and Immune System in IBS
• Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
• Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
• Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome
• Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients
• Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
• Study of TNF-Antagonism in the Metabolic Syndrome (II)
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
• Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome
• Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes
• Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
• Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
• Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
• SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)
• A Study of Pyridostigmine in Postural Tachycardia Syndrome
• Study of TNF-Antagonism in Metabolic Syndrome
• Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity
• Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant
• The Effect of Growth Hormone in Very Young Girls With Turner Syndrome
• Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
• The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.
• Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
• Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation
• Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation
• Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)
• Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
• Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
• An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome
• Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
• Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
• A Study of BMS-562086 in Patients With Irritable Bowel Syndrome
• CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors
• Lifestyle Modification and Metformin Use in the Treatment of HIV
• Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes
• Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
• DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
• AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS
• Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.
• ROMEO (Rosuvastatin in Metabolic syndrOme)
• Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
• A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• Sirolimus for Autoimmune Disease of Blood Cells
• Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
• Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
• Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
• Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
• A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
• Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome
• A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.
• Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms
• The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)
• Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome
• A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
• Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients
• Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
• Testosterone Effects on Men With the Metabolic Syndrome
• Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
• Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
• Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
• The Effects of Thalidomide on Symptom Clusters
• Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS)
• Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
• Vitamins and Minerals for Children With Downs Syndrome
• Immunotherapy of the Paraneoplastic Syndromes
• Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)
• Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers
• Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
• Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
• A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS
• 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
• Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
• Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
• Comparison of Keppra and Clonidine in the Treatment of Tics
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
• 11ß-HSD1 and Metabolic Syndrome
• Noradrenalin vs Terlipressin in Hepatorenal Syndrome
• Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
• T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts
• IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
• Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
• Simvastatin Therapy in Women With Polycystic Ovary Syndrome.
• XP13512 vs. Placebo in Patients With Restless Legs Syndrome.
• Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
• Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome
• Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
• A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
• Rituximab Treatment in Sjogren's Syndrome
• A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome
• Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
• Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
• Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS
• Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
• Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
• Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome
• Belinostat in Treating Patients With Myelodysplastic Syndromes
• The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
• Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies
• Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
• Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances
• Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
• Efficacy of Pentoxifylline on Primary Nephrotic Syndrome
• PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma
• Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
• Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
• Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
• A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
• Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease
• Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
• A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS
• PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
• Androgen Effect on Klinefelter Syndrome Motor Outcome
• Dietary Supplements for the Treatment of Angelman Syndrome
• Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure
• The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)
• An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia
• Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
• Exenatide and Metformin Therapy in Overweight Women With PCOS
• A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
• Pilot Study of Raptiva to Treat Sjogren's Syndrome
• A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies
• Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
• Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
• XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.
• Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
• The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: A Pilot Study
• Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow
• Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide
• Long-term Study Of Ropinirole In Restless Legs Syndrome
• L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes
• A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism
• Phase II 5-Azacytidine Plus VPA Plus ATRA
• The Effects of Cilnidipine on Metabolic Syndrome Improvement
• Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
• A Phase I/II Study of MGCD0103 With Azacitidine in Patients With High-Risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia
• A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes
• A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes
• Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
• Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
• Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
• Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS)
• Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors
• Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
• Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
• RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
• The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome
• Inhaled Prostacyclin for Adult Respiratory Distress Syndrome (ARDS) and Pulmonary Hypertension
• Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
• Safety Study of Apixaban in Recent Acute Coronary Syndrome
• Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.
• Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
• Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
• Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome
• Long Term Tapering or Standard Steroids for Nephrotic Syndrome
• Effect of Growth Hormone in Metabolic Syndrome
• Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
• Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
• Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome
• Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
• 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes
• Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
• Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
• SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
• Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL
• VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt
• Oral Clofarabine Study in Patients With Myelodysplastic Syndrome
• A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI
• XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.
• PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome
• Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
• Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
• Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
• Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
• Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome
• An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome
• Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome
• Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
• Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
• 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
• Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
• Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
• Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome
• Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
• Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
• A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome
• Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy
• A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
• A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
• Aripiprazole in the Treatment of Tourette's Syndrome
• Synchronization and Desynchronization Between Circadian Rhythms in Patients With Delayed Sleep Phase Syndrome (DSPS)
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
• Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
• Faslodex in McCune Albright Syndrome
• Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
• Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients
• A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
• Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
• Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
• Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
• EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes
• Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
• Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
• A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy
• A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy
• A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
• Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
• Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome
• Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
• Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome
• Bosentan in Treatment of Pulmonary Arterial Hypertension
• Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
• Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
• An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome
• Bortezomib in Treating Patients With Myelodysplastic Syndromes
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)
• Omalizumab to Treat Hyper-IgE (Job's) Syndrome
• A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes
• Rifaximin for the Treatment of Irritable Bowel Syndrome
• Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
• Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
• Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®
• Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
• Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
• G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
• Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
• Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)
• A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome
• A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
• The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes
• A Study of the Combination of Electrical Stimulation and Dysport® in Myofascial Pain Syndrome.
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
• This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Acces
• Effectiveness of Rituximab in Pediatric OMS Patients.
• Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome
• Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome
• Rotigotine Restless Legs Syndrome Dose Finding Trial
• Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities
• Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome
• Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome
• Memantine and Down's Syndrome
• Nitric Oxide Administration for Acute Respiratory Distress Syndrome
• A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
• Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)
• Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)
• Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
• Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
• Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
• Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)
• 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
• Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
• A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
• Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
• Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
• Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia
• Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam
• Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
• Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness
• To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
• Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)
• A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
• Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL
• The Effects of Aripiprazole on Patients With Metabolic Syndrome
• Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
• An Open-Label Trial of Donepezil in Fragile X Syndrome
• Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome
• Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome
• A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome
• DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)
• Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan
• Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
• A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
• Ampligen in Chronic Fatigue Syndrome
• The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
• A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c
• KL₄Surfactant Treatment in Patients With ARDS
• LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
• Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome
• An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.
• A Randomized, Placebo-controlled, Tourette Syndrome Study.
• Oral Contraceptives in the Metabolic Syndrome
• Treatment of Zollinger-Ellison Syndrome With Prevacid
• Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
• Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome
• Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
• Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
• Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
• Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML
• Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS
• Botox as a Treatment for Chronic Male Pelvic Pain Syndrome
• Somatropin Treatment to Final Height in Turner Syndrome
• Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
• A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
• Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
• Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function
• Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss
• Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
• Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain
• Stem Cell Transplant w/Laronidase for Hurler
• Stem Cell Transplant for Bone Marrow Failure Syndromes
• Stem Cell Transplant for Immunologic or Histiocytic Disorders
• T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
• Prader-Willi Syndrome and Appetite
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
• A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome
• The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
• Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
• A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
• Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome
• Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
• Metformin in Assisted Reproduction-MET-AR-study
• Metformin in Pregnant PCOS Women
• Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome
• Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome
• A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)
• Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD
• Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)
• Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome
• Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome
• Pioglitazone Treatment in Polycystic Ovary Syndrome
• A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients
• Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome
• Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
• Ropinirole Tablets In Young Patients With Restless Legs Syndrome
• Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome
• A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
• Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
• Gabapentin for Carpal Tunnel Syndrome
• A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
• Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome
• Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
• Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome
• Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome
• Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
• Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
• Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
• Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)
• Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome
• Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
• Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome
• Study of Colchicine to Prevent the Postpericardiotomy Syndrome
• Chromium Picolinate for the Treatment of Metabolic Syndrome
• 6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
• Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
• Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients
• Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
• Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
• Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndr
• Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
• Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes
• Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
• A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease
• Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients
• Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia
• Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders
• SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.
• Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure
• Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
• Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
• Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome
• Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
• Campath-1H + FK506 and Methylprednisolone for GVHD
• Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
• A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies
• Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
• Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
• Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
• Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
• Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
• Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
• Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
• Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
• Anti-CD20 Antibody Therapy for Sjogren's Syndrome
• A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
• MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
• Hyporeactivity and Gulf War Illness
• Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes
• MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas
• SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
• Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
• Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
• A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
• Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
• Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
• Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
• Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
• XK469R in Treating Patients With Refractory Hematologic Cancer
• A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome
• Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia
• Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
• Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
• Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome
• Rituximab to Treat Stiff Person Syndrome
• EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
• Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
• Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
• 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
• Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
• Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
• Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
• Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
• Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
• Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
• CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
• Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
• VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
• OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
• T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies
• Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
• Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
• Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
• Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)
• 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
• Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
• Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
• Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
• Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
• A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
• Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
• A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
• AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)
• VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
• Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
• Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
• Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
• Treatment of Infertility in Women With Polycystic Ovary Syndrome
• Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
• Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
• A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)
• Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
• Modafinil to Treat Fatigue in Post-Polio Syndrome
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
• Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)
• Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
• Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
• Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome
• Brain Imaging and Pain in Irritable Bowel Syndrome
• Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
• Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
• Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
• Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
• Paricalcitol in Treating Patients With Myelodysplastic Syndrome
• Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
• Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
• Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
• Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
• Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS)
• Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
• Vitamin E in Aging Persons With Down Syndrome
• Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
• Arimidex in McCune Albright Syndrome
• Effects of CX516 on Functioning in Fragile X Syndrome and Autism
• Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
• Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
• Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
• NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
• Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
• Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
• A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
• Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS)
• Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
• VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
• Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
• Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
• Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
• Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
• Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
• PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinas
• Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes
• A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk My
• Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
• Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome
• Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
• Decitabine Versus Supportive Care in Adults With Advanced-stage MDS
• Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
• Pyroxamide in Treating Patients With Advanced Cancer
• FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma
• Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies
• Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
• Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
• Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
• Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome
• Carperitide in Acute Respiratory Distress Syndrome (ARDS)
• Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
• Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
• The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome
• Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
• Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
• Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
• Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
• Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
• Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
• Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)
• Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
• Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer
• A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
• Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
• S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
• Thalidomide in Treating Patients With Myelodysplastic Syndrome
• Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
• MS-275 in Treating Patients With Hematologic Cancer
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
• Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
• Vitamin D Metabolism and the Williams Syndrome
• Hormone Replacement Therapy to Treat Turner Syndrome
• Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome
• Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
• Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
• Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
• Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk My
• Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Non-Ablative Allo HSCT For Hematologic Malignancies or SAA
• Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
• Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
• Neurotropin to Treat Chronic Neuropathic Pain
• Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
• Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
• Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
• BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
• Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
• Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
• Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders
• Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
• Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
• Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia
• Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
• Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy
• Tipifarnib in Treating Patients With Advanced Hematologic Cancer
• Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation
• Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
• Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia
• S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
• Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
• Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
• Tipifarnib in Treating Patients With Myelodysplastic Syndromes
• Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
• Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
• Bone Marrow Transplant in Treating Patients With Hematologic Cancers
• Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
• Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
• Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome
• Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
• Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
• Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
• Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
• Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• 506U78 in Treating Patients With Lymphoma
• PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
• Leucovorin for the Treatment of 5 q Minus Syndrome
• Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
• Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
• Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
• Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
• Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
• Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome
• Study of the Pathogenesis of Rett Syndrome
• Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome
• Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting
• Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity
• Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome
• Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
• Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
• Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
• Study of Bile Acids in Patients With Peroxisomal Disorders
• Randomized Study of Pergolide in Children With Tourette Syndrome
• Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
• Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
• Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome
• Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
• Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
• EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
• Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
• Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
• 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
• Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
• Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
• Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
• 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
• Chemotherapy in Treating Patients Who Have Hematologic Cancer
• Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
• 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
• Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
• Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
• Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
• Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
• Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
• Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
• Treatment for Chronic Pain in Patients With Advanced Cancer
• Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
• Topotecan in Treating Patients With Myelodysplastic Syndrome
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
• Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
• Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
• Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
• Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
• Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• Decitabine in Treating Patients With Myelodysplastic Syndrome
• Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions
• Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer
• Combination Chemotherapy in Treating Patients With Advanced Cancer
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
• Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma
• Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
• Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
• Amifostine in Treating Patients With Myelodysplastic Syndrome
• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
• Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
• Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
• Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
• Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant
• Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
• T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia
• Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
• Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome
• A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome
• Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome
• Etanercept Therapy for Sjogren's Syndrome
• New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
• A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
• Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
• Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
• Pilot Study of Thalidomide to Treat Sjogren's Syndrome
• DHEA Treatment for Sjogren's Syndrome
• Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
• Thalidomide to Treat Oral Lesions in HIV-Infected Patients
• A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes
• The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
• A Treatment Study for Premenstrual Syndrome (PMS)
• Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
• Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
• Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas
• A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome
• A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
• A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
• A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
• Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
• Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial
• Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration
• Prevention of Coronary Aneurysms in Kawasaki Syndrome